filename,patient_barcode,bcr_sample_uuid,histological_type,days_to_sample_procurement,path_confirm_report_attached,method_of_sample_procurement,other_method_of_sample_procurement,other_vessel_used,vessel_used,sample_prescreened,tumor_weight,country,tumor_nuclei_percent,tumor_necrosis_percent,days_to_pathology_review,path_confirm_tumor_nuclei_metrics,path_confirm_tumor_necrosis_metrics,path_confirm_diagnosis_matching,reason_path_confirm_diagnosis_not_matching,other_dx,history_of_neoadjuvant_treatment,consent_or_death_status,days_to_consent,burkitt_clinical_variant,ffpe_tumor_slide_submitted,site_of_disease,site_of_disease_description,site_of_disease_text,submitted_for_lce,digital_image_submitted,top_slide_submitted,File ID,Data Category,Data Type,Project ID,Case ID,Sample ID,Sample Type,id,md5,size,state,HRD,Telomeric AI,LST,HRD-sum,Cancer_type,annotation,HRDscore
01ddf9de-8532-4a68-af48-fec5bed7e78d.htseq.counts,TCGA-QQ-A8VB,20F9B5A5-8C63-43BE-9247-1EC3F2D07CEA,Malignant Peripheral Nerve Sheath Tumors (MPNST),917,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,270,United States,80,0,4760,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,917,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,c58c14ea-5d5b-4f42-9b5c-58df76edb524,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A8VB,TCGA-QQ-A8VB-01A,Primary Tumor,c58c14ea-5d5b-4f42-9b5c-58df76edb524,ac7faa690a9e37d37a09e158cf83d054,256260,released,6,6,8,20,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
03c093c1-9198-4bb9-994b-b81871afeef6.htseq.counts,TCGA-HB-A43Z,A6BBEE06-44BF-446A-8D21-550AA6E71960,Leiomyosarcoma (LMS),5,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,929,United States,70,5,35,YES,YES,YES,[Not Available],"Yes, History of Synchronous/Bilateral Malignancy",No,Consented,5,[Not Available],Digital Image,Uterus,[Not Available],[Not Available],[Not Available],NO,NO,6471065e-e4f6-4ac0-aa9b-79c2f074b325,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HB-A43Z,TCGA-HB-A43Z-01A,Primary Tumor,6471065e-e4f6-4ac0-aa9b-79c2f074b325,180a4734dc4c731e78d7d97fc8d05e4c,254893,released,14,26,15,55,Leiomyosarcoma-Uterus,uLMS,HRD-high
0682f782-419e-4c8f-825d-21e28ca49e84.htseq.counts,TCGA-DX-A8BG,3E8C0319-B011-4030-B0D4-3EA2F48FE7D8,Myxofibrosarcoma,61,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,99,0,133,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,48,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,e8042a9b-43c5-4576-bc73-7413d5b1baac,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BG,TCGA-DX-A8BG-01A,Primary Tumor,e8042a9b-43c5-4576-bc73-7413d5b1baac,d0d56d7dabbe149d5256cf6d6cae115b,250090,released,13,29,28,70,Myxofibrosarcoma,MFS,HRD-high
06c7af2d-2bce-4de3-9fc0-755b5284f2f5.htseq.counts,TCGA-DX-AB2O,46BE2946-A6F4-426A-A589-3A616CB77ECA,Undifferentiated Pleomorphic Sarcoma (UPS),36,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,2355,YES,YES,YES,[Not Available],No,No,Consented,17,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,0c82301e-0d90-4517-b504-cde894d91391,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2O,TCGA-DX-AB2O-01A,Primary Tumor,0c82301e-0d90-4517-b504-cde894d91391,69b79a8c5de2a8f6e5f344e74bdee2f5,253785,released,15,25,15,55,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
06fdc545-380d-4ff8-97d7-d8e63f41e5b6.htseq.counts,TCGA-WK-A8Y0,310B09B7-7762-40A9-AEFA-B356C6341CF5,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,0,1355,YES,YES,YES,[Not Available],No,No,Consented,-3,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],YES,NO,d4328ac6-27dc-4106-bcc2-ca27fc4559f0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8Y0,TCGA-WK-A8Y0-01A,Primary Tumor,d4328ac6-27dc-4106-bcc2-ca27fc4559f0,aa8411367a681cb7b02441e8b4493f12,249298,released,10,12,5,27,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
0825b4ec-fd45-483f-86fb-8a5f9015c14b.htseq.counts,TCGA-QC-A7B5,F3AA3F2A-3CC2-4B10-B764-63D1B32A2F5F,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,100,United States,80,1,61,YES,YES,YES,[Not Available],No,No,Consented,13,[Not Available],NO,Head/Neck,[Not Available],[Not Available],[Not Available],NO,YES,475f30b2-8849-4fd3-81d1-31b895acb5d9,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QC-A7B5,TCGA-QC-A7B5-01A,Primary Tumor,475f30b2-8849-4fd3-81d1-31b895acb5d9,2df6b4f22b2997defd2812ae65a65c11,252059,released,4,11,7,22,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
09ab0fec-f6bf-4c7e-bb92-d9de298c42eb.htseq.counts,TCGA-DX-A3U6,ACEA4025-F740-4A60-AD51-EAF61964256B,Dedifferentiated liposarcoma,67,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,209,YES,YES,YES,[Not Available],No,No,Consented,49,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,55bd2eee-823c-4786-a77d-94ba52e9a2ac,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3U6,TCGA-DX-A3U6-01A,Primary Tumor,55bd2eee-823c-4786-a77d-94ba52e9a2ac,cd0d89ffe0bb7c58a4dbe9bd58cf0065,250266,released,0,0,1,1,Dedifferentiated liposarcoma,ddLPS,HRD-low
09e38d91-d811-4b29-b40a-e5a79d236043.htseq.counts,TCGA-DX-A6B8,29928748-9899-49B8-8830-DA26ECD88E0E,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,5,3359,YES,YES,YES,[Not Available],No,No,Consented,-6,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,28719eae-2880-486f-9360-e7023ee6d750,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6B8,TCGA-DX-A6B8-01A,Primary Tumor,28719eae-2880-486f-9360-e7023ee6d750,d50e3161863be2df659041b4bd8c6f59,245234,released,14,15,14,43,Leiomyosarcoma,LMS,HRD-high
0a105b62-4362-46b0-96d4-a1336ee3117b.htseq.counts,TCGA-FX-A2QS,5402D273-3B02-4BF7-A0A4-625A59FED4CC,Dedifferentiated liposarcoma,14,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,207,United States,90,5,77,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,cea88741-d03f-46df-a46b-104060d81911,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A2QS,TCGA-FX-A2QS-01A,Primary Tumor,cea88741-d03f-46df-a46b-104060d81911,ae69aeb718087e5f8fc93a3610f93ba9,251867,released,1,23,10,34,Dedifferentiated liposarcoma,ddLPS,HRD-low
0b3957f2-b010-44ef-8376-455427a5e158.htseq.counts,TCGA-SI-A71P,B89AB8AF-5C5E-4E75-9C85-D88E6406D182,Malignant Peripheral Nerve Sheath Tumors (MPNST),14,YES,Excisional Biopsy,[Not Applicable],Biospecimen Storage Bag,Other,YES,180,United States,95,0,265,YES,YES,YES,[Not Available],No,No,Consented,141,[Not Available],NO,[Not Available],[Not Available],[Not Available],[Not Available],NO,YES,54059775-7e80-4b2e-9796-d897348a57bd,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SI-A71P,TCGA-SI-A71P-01A,Primary Tumor,54059775-7e80-4b2e-9796-d897348a57bd,eaeccfcf52af426a80dfb46f0cc4b671,253308,released,11,13,9,33,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
0cfeaebb-ab33-4711-9c86-f15110041ba9.htseq.counts,TCGA-3B-A9HO,697BD072-F6BD-4545-9C30-2C61ADE688FE,Dedifferentiated liposarcoma,56,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,72,United States,95,1,96,YES,YES,YES,[Not Available],[Discrepancy],[Discrepancy],Consented,49,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,095f8ccb-1b99-40c0-87b9-4eb3e2a939b4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HO,TCGA-3B-A9HO-01A,Primary Tumor,095f8ccb-1b99-40c0-87b9-4eb3e2a939b4,cc78c5b277095b7435b075a59cd34e76,245764,released,6,7,4,17,Dedifferentiated liposarcoma,ddLPS,HRD-low
0d3f6c60-6dac-4bc3-8152-72e558f8b2f0.htseq.counts,TCGA-X6-A7W8,D25910E1-1D3D-4499-B914-448141230EB5,Myxofibrosarcoma,18,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,250,United States,70,0,24,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,186b4dcd-57c6-466b-a589-d3032b387c21,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A7W8,TCGA-X6-A7W8-01A,Primary Tumor,186b4dcd-57c6-466b-a589-d3032b387c21,376d608324b16d8f4cb9ffda62a48291,250190,released,21,35,29,85,Myxofibrosarcoma,MFS,HRD-high
0ee81f55-b068-4255-ac0a-8e91f9cb22d5.htseq.counts,TCGA-HS-A5N9,ECBC891E-ED99-4541-BDA5-EDE1F28ABA8A,Leiomyosarcoma (LMS),-25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,980,Canada,90,9,927,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,-52,[Not Available],Digital Image,Uterus,[Not Available],[Not Available],[Not Available],NO,NO,43e41c7f-269a-4ed0-8ba2-93e2dfc77309,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HS-A5N9,TCGA-HS-A5N9-01A,Primary Tumor,43e41c7f-269a-4ed0-8ba2-93e2dfc77309,21cd9c6c66c60dd8d3d6b67a830e6c64,248021,released,2,26,12,40,Leiomyosarcoma-Uterus,uLMS,HRD-low
0f8d7e4c-f855-4c7d-8a1b-5637f2b5cbc5.htseq.counts,TCGA-3B-A9I3,E315F6EE-EBB1-412A-A9A5-17B86F5DC60F,Leiomyosarcoma (LMS),28,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,84,United States,100,5,88,YES,YES,YES,[Not Available],No,No,Consented,21,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,efcbfc54-cc1f-477c-8351-b7691c6c47de,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9I3,TCGA-3B-A9I3-01A,Primary Tumor,efcbfc54-cc1f-477c-8351-b7691c6c47de,8ff1966e8fe6e644eae0218ec7d508d8,254056,released,9,16,10,35,Leiomyosarcoma,LMS,HRD-low
100388e5-802d-44ff-9fdc-c7e8b425fd4b.htseq.counts,TCGA-X6-A8C6,50906D74-4CE3-4E48-A0FD-605A80ED0F32,Myxofibrosarcoma,18,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,440,United States,95,3,605,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,416,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,8f2e7e0d-80f8-4c3c-bc3f-321e8535d8b5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A8C6,TCGA-X6-A8C6-01A,Primary Tumor,8f2e7e0d-80f8-4c3c-bc3f-321e8535d8b5,0ea46f708e907f490378dc5d0dd33d61,254499,released,30,32,23,85,Myxofibrosarcoma,MFS,HRD-high
1073b30c-8404-40e2-827a-2259f0f63137.htseq.counts,TCGA-QC-AA9N,83B89602-D430-4B8C-B29B-EBDECD9415A5,Undifferentiated Pleomorphic Sarcoma (UPS),25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,150,United States,90,15,56,YES,YES,YES,[Not Available],No,No,Consented,19,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,74cdbee2-a75a-4b3b-b022-cdd315c0b74d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QC-AA9N,TCGA-QC-AA9N-01A,Primary Tumor,74cdbee2-a75a-4b3b-b022-cdd315c0b74d,2f9e523c89b2d9bdb424dd55badced09,254338,released,17,24,12,53,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
11b4ee52-88d4-4055-820f-ac02fec0b2b8.htseq.counts,TCGA-DX-A8BM,5FF35D01-C4AB-408A-92CB-422AA4B3B4B5,Undifferentiated Pleomorphic Sarcoma (UPS),29,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,99,1,965,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,722921df-1443-4aa7-bdff-db16442662af,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BM,TCGA-DX-A8BM-01A,Primary Tumor,722921df-1443-4aa7-bdff-db16442662af,5c12d5cfff5c3e5e46224a7fb0afd5f4,251510,released,10,26,23,59,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
12a2d93e-8567-4a55-a3f3-4c94c51ffb6a.htseq.counts,TCGA-IE-A3OV,31EB46E1-AEDE-4AE4-AB2B-1F85B63DA6C9,Leiomyosarcoma (LMS),16,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,280,United States,90,0,2862,YES,YES,YES,[Not Available],No,No,Consented,16,[Not Available],NO,Extremities,[Not Available],[Not Available],NO,NO,YES,cb849ac4-3f3b-4056-aadb-34a7118a00cb,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IE-A3OV,TCGA-IE-A3OV-01A,Primary Tumor,cb849ac4-3f3b-4056-aadb-34a7118a00cb,4915240627c77cc95c50bcea399c947f,252649,released,8,23,14,45,Leiomyosarcoma,LMS,HRD-high
138485c1-4e31-4d40-a1c0-af9448f4b650.htseq.counts,TCGA-3B-A9HR,D49488BE-65DD-419F-A768-E60D454417A5,Leiomyosarcoma (LMS),58,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,99,United States,99,0,98,YES,YES,YES,[Not Available],No,No,Consented,35,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,0bf1f68f-8349-4906-8989-b36e7e1390f0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HR,TCGA-3B-A9HR-01A,Primary Tumor,0bf1f68f-8349-4906-8989-b36e7e1390f0,6f661ced1917b2ca4812af3cdb8f0db0,253794,released,8,19,16,43,Leiomyosarcoma,LMS,HRD-high
14aa3bdb-5c34-4fb4-91b8-876faf41674d.htseq.counts,TCGA-RN-A68Q,767917C5-5A72-46B6-A186-38D6A5562749,Malignant Peripheral Nerve Sheath Tumors (MPNST),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,150,United States,75,0,844,YES,YES,YES,[Not Available],No,No,Consented,2,[Not Available],NO,[Not Available],[Not Available],[Not Available],[Not Available],NO,YES,b62764d8-8b99-4fd3-bfb1-11d40e406198,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-RN-A68Q,TCGA-RN-A68Q-01A,Primary Tumor,b62764d8-8b99-4fd3-bfb1-11d40e406198,7c6fa603cd30415be61db520272d9a28,251638,released,0,0,1,1,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
16a96f90-6ce8-433f-a409-39a36fe354b2.htseq.counts,TCGA-K1-A6RV,467E7743-8C7E-4A22-ACE1-492A9BC17A89,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,310,United States,40,0,112,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,4e0e7a34-e8c9-429e-b753-c547d57a159c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A6RV,TCGA-K1-A6RV-01A,Primary Tumor,4e0e7a34-e8c9-429e-b753-c547d57a159c,c0524c539cfdf57b4a0c7929d0fe6b92,249087,released,13,23,11,47,Leiomyosarcoma,LMS,HRD-high
17caf320-bbef-4430-a3db-5192cbefd354.htseq.counts,TCGA-DX-AB32,892E17AF-42C6-437A-8816-0441E56362A4,Myxofibrosarcoma,63,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,5,2843,YES,YES,YES,[Not Available],"Yes, History of Synchronous/Bilateral Malignancy",No,Consented,58,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,8ca51fdd-eead-4ae7-8cad-73de1973f817,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB32,TCGA-DX-AB32-01A,Primary Tumor,8ca51fdd-eead-4ae7-8cad-73de1973f817,f78b3384d4e69333fa6943ef993d2643,248422,released,19,15,16,50,Myxofibrosarcoma,MFS,HRD-high
17fd8633-6271-45f3-9e8a-60d093be9e6b.htseq.counts,TCGA-MJ-A850,A1D803B0-028E-44C2-B422-7B1BCBBFC0C1,Synovial Sarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,55,United States,70,0,209,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Head/Neck,[Not Available],[Not Available],[Not Available],NO,YES,0dbb49d7-1dca-4909-9e94-203679995209,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MJ-A850,TCGA-MJ-A850-01A,Primary Tumor,0dbb49d7-1dca-4909-9e94-203679995209,0c9eb4a7475b3892ee43c88078d0bd7d,255381,released,0,0,0,0,Synovial Sarcoma,SS,HRD-low
18db6e47-43ce-4438-8a5d-e355e1016f7c.htseq.counts,TCGA-X9-A971,1548E53F-F0DD-4A13-825D-093345664406,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],wrapped in foil; then stored in bag,Other,YES,246,United States,90,10,190,YES,YES,YES,[Not Available],No,No,Consented,145,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,11aa5102-3141-48c4-bcce-c17d59f9d52f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X9-A971,TCGA-X9-A971-01A,Primary Tumor,11aa5102-3141-48c4-bcce-c17d59f9d52f,d04bad8db1a39cf856a548d9958261b4,253544,released,7,24,9,40,Leiomyosarcoma,LMS,HRD-low
1a529692-842a-4201-aea6-7e0fb3f459e7.htseq.counts,TCGA-DX-AB36,4B4C7D94-6C3D-4157-A307-23819D167BFE,Dedifferentiated liposarcoma,23,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1168,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,10,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,5f00a834-832d-4a8c-a1ab-d66838518b3c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB36,TCGA-DX-AB36-01A,Primary Tumor,5f00a834-832d-4a8c-a1ab-d66838518b3c,d5ae7ec276715d5c78353d612de48b4a,246114,released,8,7,4,19,Dedifferentiated liposarcoma,ddLPS,HRD-low
1a8db727-5014-4e40-a9ae-96fbf81da0f7.htseq.counts,TCGA-DX-A3UB,0C0A7638-3732-4664-A26D-133C430941A7,Leiomyosarcoma (LMS),90,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,70,0,1120,YES,YES,YES,[Not Available],No,No,Consented,82,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,d18496d8-715e-4ba5-bb35-eff1d9ae1629,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3UB,TCGA-DX-A3UB-01A,Primary Tumor,d18496d8-715e-4ba5-bb35-eff1d9ae1629,f6b751ae8d69d873af7fbf815a31d876,244211,released,4,1,2,7,Leiomyosarcoma,LMS,HRD-low
1b168308-63be-400e-bb06-3f3084872e71.htseq.counts,TCGA-DX-A6YX,5FE06294-B8B6-4E3F-A6EA-DC981CD9BB05,Myxofibrosarcoma,25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,2832,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,a04d86db-29e8-4425-aa78-2b167175ef04,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YX,TCGA-DX-A6YX-01A,Primary Tumor,a04d86db-29e8-4425-aa78-2b167175ef04,2a7ba42a6d1f51053ff6b62d489764ba,249187,released,18,11,10,39,Myxofibrosarcoma,MFS,HRD-low
1c0083be-2cfe-4d97-8e80-a00f42cbffa7.htseq.counts,TCGA-DX-AB2L,64BA1D3A-D1D8-44C7-B654-76D770E1A2EE,Myxofibrosarcoma,33,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,1611,YES,YES,YES,[Not Available],No,No,Consented,50,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,05c59d32-f167-417c-abce-badaaa9b40e4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2L,TCGA-DX-AB2L-01A,Primary Tumor,05c59d32-f167-417c-abce-badaaa9b40e4,f71293ac0cc3cf3605e530e96a6574dc,245252,released,0,0,0,0,Myxofibrosarcoma,MFS,HRD-low
1ffab02f-222f-4731-978c-a0e04581c172.htseq.counts,TCGA-DX-A1KW,4C93C0A4-73C4-48EF-91E0-40B2143833BC,Dedifferentiated liposarcoma,52,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,567,YES,YES,YES,[Not Available],No,No,Consented,48,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,2df2aed3-6fb3-474d-9f6b-7cfefc3a5a07,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1KW,TCGA-DX-A1KW-01A,Primary Tumor,2df2aed3-6fb3-474d-9f6b-7cfefc3a5a07,0ac9cde82532b04e3515184eeecc43db,249258,released,7,19,8,34,Dedifferentiated liposarcoma,ddLPS,HRD-low
20144c76-d6ee-4589-aac6-0fe8d4174197.htseq.counts,TCGA-K1-A3PN,3DB0DE29-F0A6-4CEA-BEC5-22164E795A43,Leiomyosarcoma (LMS),16,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,900,United States,80,2,2003,YES,YES,YES,[Not Available],No,No,Consented,1015,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,6ce75358-0155-4a92-ba3d-a4b2738afbd4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A3PN,TCGA-K1-A3PN-02A,Recurrent Tumor,6ce75358-0155-4a92-ba3d-a4b2738afbd4,8f3463d81406ca0d8608506d60f8a684,250270,released,6,11,3,20,Leiomyosarcoma,LMS,HRD-low
22c0f3a2-a83b-41ed-b92b-faf854aee913.htseq.counts,TCGA-WK-A8XO,EAF6C1E3-0365-4F55-BA58-7353A6703116,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,0,1287,YES,YES,YES,[Not Available],No,No,Consented,-8,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,2ef00350-eb9c-4c24-859e-b178e95ede0b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8XO,TCGA-WK-A8XO-01A,Primary Tumor,2ef00350-eb9c-4c24-859e-b178e95ede0b,5d54162928fd1f6b6bbfffabe27bc7f8,249363,released,7,11,4,22,Dedifferentiated liposarcoma,ddLPS,HRD-low
23758664-22b8-4bc5-9a03-061619380b20.htseq.counts,TCGA-X6-A8C7,5957204D-70A6-4E29-8719-CC636BA4D908,Synovial Sarcoma,19,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,170,United States,95,0,140,YES,YES,YES,[Not Available],No,No,Consented,49,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,486eadc6-353b-4d42-88dc-a1877740cbbc,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A8C7,TCGA-X6-A8C7-01A,Primary Tumor,486eadc6-353b-4d42-88dc-a1877740cbbc,aadcdb46996dadd203258bcc7d7af193,255501,released,2,2,1,5,Synovial Sarcoma,SS,HRD-low
254023bc-c2bd-4d26-8f62-b18e2906037d.htseq.counts,TCGA-RN-AAAQ,44A95FA6-EB07-4D7F-AA82-A0146F782D53,Malignant Peripheral Nerve Sheath Tumors (MPNST),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,80,0,83,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,a6d3b782-3b56-4b46-93b4-50b36f9affde,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-RN-AAAQ,TCGA-RN-AAAQ-01A,Primary Tumor,a6d3b782-3b56-4b46-93b4-50b36f9affde,cf9603f68bfecbb69ea103d1de88bc5c,250767,released,7,18,14,39,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
25798170-00b2-40d4-a281-4debb7567d2a.htseq.counts,TCGA-DX-A3M2,155FB0DC-2C45-46A8-84C9-A1447111BB8C,Dedifferentiated liposarcoma,25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,217,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,14,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,408fc243-bedd-4638-8522-a2f0f958da23,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3M2,TCGA-DX-A3M2-01A,Primary Tumor,408fc243-bedd-4638-8522-a2f0f958da23,cf510d58fc6dfb428570a49edb09b6e9,245643,released,10,29,14,53,Dedifferentiated liposarcoma,ddLPS,HRD-high
268c6151-2651-40b7-a298-2a22891b6cef.htseq.counts,TCGA-DX-A6BB,030ED394-9316-4CE3-96E3-680E3BCB1595,Leiomyosarcoma (LMS),38,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,354,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,b3c9cdf7-203b-4a66-a3a3-cc3c0c0aee32,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6BB,TCGA-DX-A6BB-01A,Primary Tumor,b3c9cdf7-203b-4a66-a3a3-cc3c0c0aee32,6d6df46c1b60149671b55cf2aae583a7,249715,released,7,10,7,24,Leiomyosarcoma,LMS,HRD-low
28a25a5d-566e-4d35-97f1-5972b6ea67cb.htseq.counts,TCGA-DX-AB2E,96403BA9-28A3-4BFD-A53C-6D9ECD05EBB4,Myxofibrosarcoma,49,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,20,122,YES,YES,YES,[Not Available],No,No,Consented,31,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,69b4ca73-f928-41bf-9cdf-11a00c079c68,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2E,TCGA-DX-AB2E-01A,Primary Tumor,69b4ca73-f928-41bf-9cdf-11a00c079c68,dbc6682b3cbd60b8ada63f69dfd2b1fb,247570,released,13,22,7,42,Myxofibrosarcoma,MFS,HRD-high
2915d064-12c1-4040-b898-2ed63aad7746.htseq.counts,TCGA-SG-A6Z4,F035A57E-BE4D-49FF-A96F-1CA75F4A6B92,Undifferentiated Pleomorphic Sarcoma (UPS),15,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,380,United States,80,20,21,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,154e3835-cd67-47c7-9611-083d4933163d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SG-A6Z4,TCGA-SG-A6Z4-01A,Primary Tumor,154e3835-cd67-47c7-9611-083d4933163d,3d31906328846bf89c2446f4d7977fa5,255252,released,17,18,10,45,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
29750f87-1959-43c4-9ad6-a0afa3fb1fc2.htseq.counts,TCGA-DX-A3LY,A5697D2C-8E1A-42BE-8EBF-E57D6919BA65,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,70,0,225,YES,YES,YES,[Not Available],[Not Available],[Not Available],[Not Available],-5,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,d7145bdf-1992-4a24-8830-f9487f1f4366,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3LY,TCGA-DX-A3LY-01B,Primary Tumor,d7145bdf-1992-4a24-8830-f9487f1f4366,4a54d403fb8bcdc6afedf2c15d8a2d5c,250830,released,3,18,13,34,Dedifferentiated liposarcoma,ddLPS,HRD-low
2984412e-b086-4230-9f24-f6f97302780e.htseq.counts,TCGA-X6-A7WC,0E5DF0A8-AD22-4E91-9190-11D0CA9C86C1,Leiomyosarcoma (LMS),26,YES,Excisional Biopsy,[Not Applicable],[Not Applicable],Cryomold,YES,130,United States,95,0,658,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,987f05b8-0eef-4a6a-bb96-b618267be72c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A7WC,TCGA-X6-A7WC-01A,Primary Tumor,987f05b8-0eef-4a6a-bb96-b618267be72c,be422b03d76c49424ecb0f0e961bbe66,252264,released,10,29,23,62,Leiomyosarcoma,LMS,HRD-high
2a29763d-bf90-4489-b26f-1f05375aa1ff.htseq.counts,TCGA-HB-A3L4,D2165554-A30A-49E9-8038-C9539D487A22,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,189,United States,100,0,707,YES,YES,YES,[Not Available],No,No,Consented,-17,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,YES,NO,fbf1653a-96a7-4600-b4af-28912e27db2d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HB-A3L4,TCGA-HB-A3L4-01A,Primary Tumor,fbf1653a-96a7-4600-b4af-28912e27db2d,595cd89346181b7f817605d2493e8c7c,249827,released,14,13,18,45,Leiomyosarcoma-Uterus,uLMS,HRD-high
2b66a8a5-1e0a-4a4a-beb7-b2273b2ffb05.htseq.counts,TCGA-MJ-A68H,E452E671-C60D-4042-A06F-D7EE0BE0234E,Leiomyosarcoma (LMS),34,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,98,United States,90,0,93,YES,YES,YES,[Not Available],No,No,Consented,34,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,ff8fba5e-f6e2-4db6-87cf-11958b27bc37,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MJ-A68H,TCGA-MJ-A68H-01A,Primary Tumor,ff8fba5e-f6e2-4db6-87cf-11958b27bc37,a061e74702e26253f1e812f39aace02d,248911,released,2,18,10,30,Leiomyosarcoma,LMS,HRD-low
2b83addd-847c-473c-b7d6-8cc33d5abe14.htseq.counts,TCGA-DX-A2J4,46E59502-D5DF-428B-BEEF-6AD1439B86C6,Dedifferentiated liposarcoma,46,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,65,0,1175,YES,YES,YES,[Not Available],No,No,Consented,35,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,d1d1c9b5-7049-409d-b381-1e88ceb82a79,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A2J4,TCGA-DX-A2J4-01A,Primary Tumor,d1d1c9b5-7049-409d-b381-1e88ceb82a79,96bc85d229f14ccd592aba6497e92783,247660,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
2c60d37b-f94a-483f-b855-64c232efc219.htseq.counts,TCGA-QQ-A5VD,75B173E9-5215-4E75-B547-5DB57D4B0F33,Leiomyosarcoma (LMS),36,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,290,United States,70,0,89,YES,YES,YES,[Not Available],No,No,Consented,19,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,5dcc9c6e-c8f8-4299-a26a-4f1bb1897408,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A5VD,TCGA-QQ-A5VD-01A,Primary Tumor,5dcc9c6e-c8f8-4299-a26a-4f1bb1897408,cae63713f52bc0f3e30e68fb0808740b,250094,released,9,7,5,21,Leiomyosarcoma,LMS,HRD-low
2e3c0a9e-ddd9-4034-ad3f-ceede555db4f.htseq.counts,TCGA-JV-A5VF,976AFD99-08BA-440D-8ECD-9918AE4279CB,Leiomyosarcoma (LMS),0,YES,Incisional Biopsy,[Not Applicable],[Not Applicable],Cryovial,YES,211,United States,90,0,18,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,e2aab053-be80-4530-949f-4e37aa9a1aa6,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-JV-A5VF,TCGA-JV-A5VF-01A,Primary Tumor,e2aab053-be80-4530-949f-4e37aa9a1aa6,2cec4bfbc332d8718e9f2a8132a46fd7,249882,released,11,12,12,35,Leiomyosarcoma-Uterus,uLMS,HRD-low
3027e1dd-e4dd-4230-83c0-e95dca877cbf.htseq.counts,TCGA-DX-A2J0,A8673BA9-EF34-42CA-A73E-1EFB4F186E88,Dedifferentiated liposarcoma,55,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,2133,YES,YES,YES,[Not Available],No,No,Consented,42,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,59d70063-da3f-488c-9acd-bb7632ae3f27,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A2J0,TCGA-DX-A2J0-01A,Primary Tumor,59d70063-da3f-488c-9acd-bb7632ae3f27,49307c9785890dbc7bc0f3b9294ce2c6,256313,released,6,5,2,13,Dedifferentiated liposarcoma,ddLPS,HRD-low
30754a70-ae99-4287-a0ad-14cf0b19d81d.htseq.counts,TCGA-DX-A8BX,3F0974A2-B39B-4265-B1F9-E7D8C54CBAC5,Undifferentiated Pleomorphic Sarcoma (UPS),29,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,5,2595,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,e0027648-4c69-4079-99b5-d14b7018ac50,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BX,TCGA-DX-A8BX-01A,Primary Tumor,e0027648-4c69-4079-99b5-d14b7018ac50,ad23cb2ab5ff69b6883eea2b6b7263e7,249491,released,3,11,10,24,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
32f0ee9c-80a5-473a-80e7-206a63d8d330.htseq.counts,TCGA-DX-AATS,96D18F04-A2C7-4F86-A648-C18B5796A2A8,Undifferentiated Pleomorphic Sarcoma (UPS),14,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,5,2125,YES,YES,YES,[Not Available],No,No,Consented,3,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,f237a3e8-79bb-4dc1-82fb-7f1c89f8f1ba,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AATS,TCGA-DX-AATS-01A,Primary Tumor,f237a3e8-79bb-4dc1-82fb-7f1c89f8f1ba,8710790412a37e3716724e8b6450b9b4,246822,released,16,33,18,67,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
35acc1b2-6226-49e0-8c26-6948484b1d47.htseq.counts,TCGA-DX-A1KU,B09E1197-D6CD-4A76-8E2F-3B8AF97D2390,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,70,30,116,YES,YES,YES,[Not Available],No,No,Consented,-11,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,7bdce556-52d8-47fa-a715-8c22f48b5c10,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1KU,TCGA-DX-A1KU-01A,Primary Tumor,7bdce556-52d8-47fa-a715-8c22f48b5c10,0d14598280466bd676fd86da02d2c158,247324,released,1,16,12,29,Dedifferentiated liposarcoma,ddLPS,HRD-low
3616565b-1f84-4210-b4c9-08b286a3db0c.htseq.counts,TCGA-DX-A8BO,DDEAE3BA-7BF7-42F1-879F-C4BEC9E2D318,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,695,YES,YES,YES,[Not Available],No,No,Consented,-11,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,9c9e784f-ae76-412c-88e3-2ea67987a9ac,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BO,TCGA-DX-A8BO-01A,Primary Tumor,9c9e784f-ae76-412c-88e3-2ea67987a9ac,ca5b85208c13e56f5db7dd1c96e1ee0c,248054,released,22,20,19,61,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
36277742-e1d4-4314-afe2-4945f648e9b3.htseq.counts,TCGA-DX-AB30,1A601591-A002-421C-A8E6-1537EF3F70E0,Myxofibrosarcoma,19,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,3379,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,14,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,d8253f86-d9d1-436e-85d7-b4af8019fb63,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB30,TCGA-DX-AB30-01A,Primary Tumor,d8253f86-d9d1-436e-85d7-b4af8019fb63,466cd692df25e99a5799ce9b449529ee,256904,released,9,23,13,45,Myxofibrosarcoma,MFS,HRD-high
363c3d34-4ed6-4ac3-bf20-738ecc422de9.htseq.counts,TCGA-DX-A3UC,5F5EAD4E-89BE-4438-A32D-52AA089DA9AC,Leiomyosarcoma (LMS),20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,868,YES,YES,YES,[Not Available],No,No,Consented,15,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,3c5e3c5e-397c-4ea2-a2dc-570b3cb4fb66,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3UC,TCGA-DX-A3UC-01A,Primary Tumor,3c5e3c5e-397c-4ea2-a2dc-570b3cb4fb66,7dca523d64920062114601ee70e481df,246737,released,9,10,5,24,Leiomyosarcoma,LMS,HRD-low
37a13940-09d8-4a6f-95fe-83fa0bc0b6c2.htseq.counts,TCGA-K1-A3PO,23B9DCA0-A8A2-4798-8953-9F5A03EF7B2B,Leiomyosarcoma (LMS),11,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,460,United States,60,2,551,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,e2054010-5b2d-4072-84c7-687cafecd16f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A3PO,TCGA-K1-A3PO-11A,Solid Tissue Normal,e2054010-5b2d-4072-84c7-687cafecd16f,52913234908c0d276613851532f92578,246976,released,2,2,0,4,Leiomyosarcoma,LMS,HRD-low
383220d2-5163-4d80-b13b-3e3e17666478.htseq.counts,TCGA-MB-A8JK,980D8A35-44EF-415F-B7B2-89A4BC18515B,Undifferentiated Pleomorphic Sarcoma (UPS),11,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,300,United States,95,0,12,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],Slide,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,48ed1259-0ece-4e55-9cf3-7458d6c454f0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MB-A8JK,TCGA-MB-A8JK-01A,Primary Tumor,48ed1259-0ece-4e55-9cf3-7458d6c454f0,e25a415a71c688801f7a10b10bf99205,253397,released,14,24,11,49,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
384235f4-4697-4069-a759-0481999fd290.htseq.counts,TCGA-DX-A8BV,07A15D4D-8902-4A54-A053-2FD306E44456,Myxofibrosarcoma,41,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,3436,YES,YES,YES,[Not Available],No,No,Consented,41,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,02d77118-5faa-4160-ba5b-73834f111fc0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BV,TCGA-DX-A8BV-01A,Primary Tumor,02d77118-5faa-4160-ba5b-73834f111fc0,7c2f5582c66a6547048ed5a59a8bacc7,248999,released,12,27,19,58,Myxofibrosarcoma,MFS,HRD-high
3a1f9f5b-2c01-4023-94e9-9a34f9ae8e6f.htseq.counts,TCGA-DX-A23Z,2FAEC76F-76EB-4BEB-9B30-02F8FD087FD7,Dedifferentiated liposarcoma,28,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,1597,YES,YES,YES,[Not Available],No,No,Consented,16,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,995ed84a-a0bf-4e6d-95c8-44c00b03d28b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A23Z,TCGA-DX-A23Z-01A,Primary Tumor,995ed84a-a0bf-4e6d-95c8-44c00b03d28b,22c7f14fa0bff45a3408d9c608d344c4,247065,released,0,1,2,3,Dedifferentiated liposarcoma,ddLPS,HRD-low
3ab9fbfe-3a66-4746-b63b-ba5c15bfc602.htseq.counts,TCGA-PC-A5DL,B0969599-1E56-489E-AD92-97FAC0754A24,Leiomyosarcoma (LMS),97,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,100,0,3054,YES,YES,YES,[Not Available],No,No,Consented,97,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,adc3c48a-e897-4e39-a6d7-58b3b8c91a02,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-PC-A5DL,TCGA-PC-A5DL-01A,Primary Tumor,adc3c48a-e897-4e39-a6d7-58b3b8c91a02,3dd4228da7b4c5c7934fce776fa53b58,255019,released,8,10,4,22,Leiomyosarcoma,LMS,HRD-low
3cb7e397-f900-4bf0-9f20-6990267d1ba3.htseq.counts,TCGA-DX-A3M1,1AFCDB32-AE26-4747-A131-54E83DD84A46,Dedifferentiated liposarcoma,48,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,337,YES,YES,YES,[Not Available],No,No,Consented,43,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,b2fd7c65-5805-45ff-9bc5-9ddc8fa222af,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3M1,TCGA-DX-A3M1-01A,Primary Tumor,b2fd7c65-5805-45ff-9bc5-9ddc8fa222af,af6ad8c49649385a6a9aad981f9fac1b,251561,released,5,23,17,45,Dedifferentiated liposarcoma,ddLPS,HRD-high
3eee3276-85e6-451d-b39d-a5a51441915c.htseq.counts,TCGA-DX-A3U9,D6DD84FA-2295-4B22-8A12-13E8DA9CF3A9,Leiomyosarcoma (LMS),25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,1862,YES,YES,YES,[Not Available],No,No,Consented,210,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,aa3344d3-d956-4643-b776-5f8f605d079b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3U9,TCGA-DX-A3U9-01A,Primary Tumor,aa3344d3-d956-4643-b776-5f8f605d079b,92783a8a494a1ede7e3dbaf7a5c3b6f2,251455,released,12,15,10,37,Leiomyosarcoma,LMS,HRD-low
3f2723f9-77e2-4b85-afc7-62f4ee68bfe6.htseq.counts,TCGA-N1-A6IA,AF8434CF-5C2F-48CC-B3AC-132DFB505DBD,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,144,United States,100,0,558,YES,YES,YES,Macrodissection performed at TSS to select for a region containing an acceptable TCGA diagnosis,No,No,Consented,-2,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,c9185497-a822-4011-bbd9-289104e79d6f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-N1-A6IA,TCGA-N1-A6IA-01A,Primary Tumor,c9185497-a822-4011-bbd9-289104e79d6f,859cb7153ed49389f94a319fbc083139,250795,released,6,21,14,41,Leiomyosarcoma-Uterus,uLMS,HRD-low
4314b385-45e0-4de6-9a2a-7a1429934d0f.htseq.counts,TCGA-DX-AB2S,F9ED88A0-0919-4190-916E-BA5FB7CEA99A,Myxofibrosarcoma,61,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,3171,YES,YES,YES,[Not Available],No,No,Consented,56,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,62562adc-272f-467e-ab85-39afba967fe4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2S,TCGA-DX-AB2S-01A,Primary Tumor,62562adc-272f-467e-ab85-39afba967fe4,2cc4a606e58b0ebe259ad1cd34cb1058,250490,released,0,0,0,0,Myxofibrosarcoma,MFS,HRD-low
433f24a4-fc4c-4cec-b292-ab22801e5b91.htseq.counts,TCGA-DX-A1L2,901DFD62-799D-4E40-926E-22A5FD859B5A,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,1026,YES,YES,YES,[Not Available],No,No,Consented,-18,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,e8ece4ac-cb89-46bb-9fce-ea71745c4d3b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1L2,TCGA-DX-A1L2-01A,Primary Tumor,e8ece4ac-cb89-46bb-9fce-ea71745c4d3b,3db1a4a1dcea3c2b7563c52e14dcc986,248773,released,9,26,20,55,Dedifferentiated liposarcoma,ddLPS,HRD-high
44db1348-8a8c-4ef2-99e9-e5a13a9c81ec.htseq.counts,TCGA-DX-A7EQ,2BE1C673-33B9-4AC3-897D-A75C3D0266FB,Synovial Sarcoma,46,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,2744,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,2ed99e29-4d23-43e0-b627-645e2427ff89,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7EQ,TCGA-DX-A7EQ-01A,Primary Tumor,2ed99e29-4d23-43e0-b627-645e2427ff89,37cacd3425f8a808b45a518165f6d6fc,246623,released,2,2,1,5,Synovial Sarcoma,SS,HRD-low
459da4d7-7821-4275-a733-576e4504ce5f.htseq.counts,TCGA-DX-A48P,DDC3D466-4E2B-4E0F-A123-3D7E7FB94508,Leiomyosarcoma (LMS),242,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,413,YES,YES,YES,[Not Available],No,No,Consented,238,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,df37a40e-e270-414e-ae9b-1d16866eebe6,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48P,TCGA-DX-A48P-01A,Primary Tumor,df37a40e-e270-414e-ae9b-1d16866eebe6,d5eb68dca79f73c17385d6c4c1e750fb,250883,released,8,10,5,23,Leiomyosarcoma,LMS,HRD-low
4640f61d-4e8a-40c4-a6ee-14222dbd4e03.htseq.counts,TCGA-DX-A2J1,FA121456-0D94-472E-9FFA-25F1AAAC4E00,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,1486,YES,YES,YES,[Not Available],No,No,Consented,-4,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,602747b4-5df0-48f1-a8a2-6562ae670141,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A2J1,TCGA-DX-A2J1-01A,Primary Tumor,602747b4-5df0-48f1-a8a2-6562ae670141,1658c3fab40a62a25f7252be45cbc48c,247368,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
46f970d5-057a-41dc-839d-3928a47d031b.htseq.counts,TCGA-X6-A7WD,4CEC0557-6A01-463C-944E-4C11556222C7,Leiomyosarcoma (LMS),27,YES,Excisional Biopsy,[Not Applicable],[Not Applicable],Cryomold,YES,250,United States,90,10,203,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,1cf6d444-ca0f-4721-84a2-520e6f3325a8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A7WD,TCGA-X6-A7WD-01A,Primary Tumor,1cf6d444-ca0f-4721-84a2-520e6f3325a8,a46828d57fc8a96adfab6638b2aa3754,253343,released,10,15,11,36,Leiomyosarcoma,LMS,HRD-low
479fbe15-3c72-406f-94b6-4cd170ed9e5c.htseq.counts,TCGA-DX-A6YT,9EFF3F89-CD15-46EE-AC86-006586E1CEFE,Myxofibrosarcoma,32,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,1673,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,14,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,46b7097b-aff1-4cf4-a804-652924428210,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YT,TCGA-DX-A6YT-01A,Primary Tumor,46b7097b-aff1-4cf4-a804-652924428210,cedbd7d5a049b8b5f600242309c27a9d,250815,released,12,14,7,33,Myxofibrosarcoma,MFS,HRD-low
48290242-95ec-418c-8782-de98812b6803.htseq.counts,TCGA-QQ-A5VB,94B19FA7-A291-4FFD-A4E0-4D3E2F48DA1D,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,80,0,6902,YES,YES,YES,[Not Available],No,No,Deceased,[Not Available],[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,4dc38776-3873-4919-8195-6d6cf586b52a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A5VB,TCGA-QQ-A5VB-01A,Primary Tumor,4dc38776-3873-4919-8195-6d6cf586b52a,33233bc4a95c96d1edaffb3c09280be7,250058,released,30,30,19,79,Leiomyosarcoma,LMS,HRD-high
4972e9ed-4cfd-4544-bf96-6b881fab7032.htseq.counts,TCGA-DX-AB37,CC253802-8DEB-46A1-AF0F-1649C322DC00,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,3866,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,-5,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,5731a647-199b-475d-96e2-55aaf18ca6f2,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB37,TCGA-DX-AB37-01A,Primary Tumor,5731a647-199b-475d-96e2-55aaf18ca6f2,40090f8ca1057eae285c86ad3913a3ea,244662,released,6,5,8,19,Dedifferentiated liposarcoma,ddLPS,HRD-low
4a7fa98b-c6cb-48a9-909e-41a7efde10b2.htseq.counts,TCGA-SI-A71Q,E36CE5CC-F8B6-47F8-8102-7A18053D3DFC,Malignant Peripheral Nerve Sheath Tumors (MPNST),0,YES,Incisional Biopsy,[Not Applicable],Biospecimen Storage Bag,Other,YES,970,United States,98,0,475,YES,YES,YES,[Not Available],No,No,Consented,100,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,a8887703-c49d-47ab-b16b-7ed08b0b4fec,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SI-A71Q,TCGA-SI-A71Q-01A,Primary Tumor,a8887703-c49d-47ab-b16b-7ed08b0b4fec,4340de16c6ae7356fefc44ded600816c,257255,released,11,25,5,41,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
4b260778-e1cc-49b4-b509-8fa500bbcc76.htseq.counts,TCGA-DX-A6YQ,18258DDC-34E3-4590-87E7-C11D7A41D0D3,Myxofibrosarcoma,11,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,10,854,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,665d04df-c2bc-4281-9c63-6ac0abeb56a5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YQ,TCGA-DX-A6YQ-01A,Primary Tumor,665d04df-c2bc-4281-9c63-6ac0abeb56a5,0f3e96bc64f6bc7dae135af6a5dd87fc,252367,released,27,26,19,72,Myxofibrosarcoma,MFS,HRD-high
4cbfa498-582e-4308-bd77-3d890ad674bf.htseq.counts,TCGA-DX-A3LU,39BBAA83-8143-4E62-836E-1584B41B073B,Dedifferentiated liposarcoma,23,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,1633,YES,YES,YES,[Not Available],No,No,Consented,17,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,f7d971f4-fa8e-4e76-952f-9b9534b514e7,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3LU,TCGA-DX-A3LU-01A,Primary Tumor,f7d971f4-fa8e-4e76-952f-9b9534b514e7,8792465c7d13f6b8cd38e6ebdb87e429,246482,released,1,1,3,5,Dedifferentiated liposarcoma,ddLPS,HRD-low
4cc4a395-0028-42d7-9495-23e69ea8348c.htseq.counts,TCGA-DX-A3UE,A2679D7D-8C31-4CAA-B310-33B627D7BAB6,Leiomyosarcoma (LMS),53,NO,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,1707,YES,YES,YES,[Not Available],No,No,Consented,28,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],NO,NO,YES,0b5462ec-e757-40a8-99cc-ffe48d230dc7,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3UE,TCGA-DX-A3UE-01A,Primary Tumor,0b5462ec-e757-40a8-99cc-ffe48d230dc7,9137f48bc5e6258dbda4c15195682896,254320,released,8,8,5,21,Leiomyosarcoma,LMS,HRD-low
4e7d2e2f-610e-4771-8585-a16ffefa8c4b.htseq.counts,TCGA-X6-A7WB,1857E1ED-2584-4B12-B889-791CAF08DC5E,Leiomyosarcoma (LMS),34,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,1100,United States,95,1,736,YES,YES,YES,[Not Available],No,No,Consented,50,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,3d77867e-562d-4925-909c-0893b44a9150,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A7WB,TCGA-X6-A7WB-01A,Primary Tumor,3d77867e-562d-4925-909c-0893b44a9150,8981e3cc78907b91fe3dc5ac1842f172,254258,released,15,7,9,31,Leiomyosarcoma-Uterus,uLMS,HRD-low
4fa429e1-549c-4da6-8026-50a2b3e438fc.htseq.counts,TCGA-DX-A6BE,02300B5F-7C4F-476C-826A-5A29543C6F33,Dedifferentiated liposarcoma,46,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,70,5,504,YES,YES,YES,[Not Available],No,No,Consented,27,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,10dfd518-b72e-45c1-8040-eb0b01009144,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6BE,TCGA-DX-A6BE-01A,Primary Tumor,10dfd518-b72e-45c1-8040-eb0b01009144,c75f024e6b9cb4f4c047421c2a2ee20e,247665,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
50bbf24f-b914-4e53-98ee-0cf22b2d9f01.htseq.counts,TCGA-FX-A2QS,5402D273-3B02-4BF7-A0A4-625A59FED4CC,Dedifferentiated liposarcoma,14,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,207,United States,90,5,77,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,3c9fe8ef-e394-4d7a-9189-de6ce2169c45,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A2QS,TCGA-FX-A2QS-11A,Solid Tissue Normal,3c9fe8ef-e394-4d7a-9189-de6ce2169c45,b639eab222c3ad025e32eff0c5a0b994,251999,released,1,23,10,34,Dedifferentiated liposarcoma,ddLPS,HRD-low
5240afee-fc3e-4729-9928-588cdbea28b3.htseq.counts,TCGA-SG-A6Z7,1BD6B341-57EE-4A60-A69B-0822550BA6D1,Dedifferentiated liposarcoma,7,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,145,United States,80,20,3205,YES,YES,YES,[Not Available],No,No,Deceased,[Not Available],[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,b321bb6a-b772-44b0-a4a9-85be814f2cad,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SG-A6Z7,TCGA-SG-A6Z7-01A,Primary Tumor,b321bb6a-b772-44b0-a4a9-85be814f2cad,6ed1c62bff1e8781360b8d8b7846e9e2,257650,released,10,18,8,36,Dedifferentiated liposarcoma,ddLPS,HRD-low
557ca9d1-a5be-4252-9abc-0ae3142043e9.htseq.counts,TCGA-MO-A47P,6A35DE11-52E3-4F76-B5EE-09C2F1C7A06D,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,500,Vietnam,80,0,26,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,a166088c-5558-4d7c-9aa6-b8c1aabbeaff,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MO-A47P,TCGA-MO-A47P-01A,Primary Tumor,a166088c-5558-4d7c-9aa6-b8c1aabbeaff,ae3266835ce678bf47affb6999b0852d,257344,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
55b43c54-6b47-4a91-944d-ed5dd0d82bf8.htseq.counts,TCGA-3B-A9HU,5BD8CE88-7364-4DCF-BC4B-AC5C9F3FEF4C,Leiomyosarcoma (LMS),110,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,73,United States,100,10,161,YES,YES,YES,[Not Available],No,No,Consented,21,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,d6c8ef11-2e62-4fc3-bacf-b7fb1ca03e25,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HU,TCGA-3B-A9HU-01A,Primary Tumor,d6c8ef11-2e62-4fc3-bacf-b7fb1ca03e25,cc204bd08362ef3d033aec78343972dd,257157,released,12,7,3,22,Leiomyosarcoma,LMS,HRD-low
56249bd1-f0dc-4ed3-8aa5-5afa81b691cb.htseq.counts,TCGA-Z4-A9VC,94FC14D9-7EE7-4569-A6CA-670F6017E70C,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,Russia,90,0,120,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,e7794868-5032-464d-a539-cb42e6f2c2cd,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-Z4-A9VC,TCGA-Z4-A9VC-01A,Primary Tumor,e7794868-5032-464d-a539-cb42e6f2c2cd,382ed571725711c3005bf0e95d01abcd,254581,released,0,1,0,1,Dedifferentiated liposarcoma,ddLPS,HRD-low
56ae0262-481e-4a74-888c-9153fbd04b6d.htseq.counts,TCGA-X6-A7WA,2A5A7CA4-F61F-4E7E-BF31-92A50534D898,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,0,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,322514bd-77bc-4509-b38d-7db992bacc60,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A7WA,TCGA-X6-A7WA-01A,Primary Tumor,322514bd-77bc-4509-b38d-7db992bacc60,d9aac2131881e3ac9b6b6b97c8637ced,254945,released,3,6,2,11,Leiomyosarcoma,LMS,HRD-low
56c85936-07f8-4171-aef2-fd867b863acc.htseq.counts,TCGA-IS-A3K6,BBDE8AF5-F8D9-4D21-BB26-6486435F0F5A,Leiomyosarcoma (LMS),29,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cassette,YES,200,United States,99,0,4082,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,21,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,8a4ca930-d6a7-4b66-8836-a262f7f6c110,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IS-A3K6,TCGA-IS-A3K6-01A,Primary Tumor,8a4ca930-d6a7-4b66-8836-a262f7f6c110,89d3190d61a657036f429bda62cc6201,251766,released,5,6,6,17,Leiomyosarcoma-Uterus,uLMS,HRD-low
592f5d1c-dc62-48ce-b209-0c7c206149cb.htseq.counts,TCGA-3B-A9HY,04080CB8-430B-42FD-9D6F-0B76FBC6E297,Leiomyosarcoma (LMS),92,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,87,United States,100,0,161,YES,YES,YES,[Not Available],No,No,Consented,62,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,e93c8476-0350-4190-8752-26621a29baf9,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HY,TCGA-3B-A9HY-01A,Primary Tumor,e93c8476-0350-4190-8752-26621a29baf9,8794c2de67778768864415dbbefdb483,254110,released,7,8,2,17,Leiomyosarcoma,LMS,HRD-low
598f5dd6-5945-4d17-b718-0614e8c3f391.htseq.counts,TCGA-DX-A1L3,19A45767-ABF7-4D53-B096-B59847FC47A8,Dedifferentiated liposarcoma,15,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,648,YES,YES,YES,[Not Available],No,No,Consented,10,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,8e95f636-3960-45be-9652-6897b609f749,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1L3,TCGA-DX-A1L3-01A,Primary Tumor,8e95f636-3960-45be-9652-6897b609f749,6e0795daa75e823583368b24111fb65e,246558,released,1,3,1,5,Dedifferentiated liposarcoma,ddLPS,HRD-low
5b210841-b44b-476d-837a-d21bfcc984b3.htseq.counts,TCGA-DX-AB2G,2ED5634E-041A-4346-B7EF-D1FD739E925E,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,23,YES,YES,YES,[Not Available],No,No,Consented,-5,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,11ced33f-bae9-44d3-bf05-3ccebe178e56,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2G,TCGA-DX-AB2G-01A,Primary Tumor,11ced33f-bae9-44d3-bf05-3ccebe178e56,be1b718f28ab6a09aa452a5e7ec07645,244590,released,3,6,5,14,Dedifferentiated liposarcoma,ddLPS,HRD-low
5bd57fa2-1729-4c1c-ad66-28d753160136.htseq.counts,TCGA-PC-A5DO,84C516A9-E31E-486B-B6A6-15D6E2A6CE18,Leiomyosarcoma (LMS),42,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,100,10,2404,YES,YES,YES,[Not Available],No,No,Consented,835,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,0fd6a234-03a0-4781-8f20-330e25403e3f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-PC-A5DO,TCGA-PC-A5DO-01A,Primary Tumor,0fd6a234-03a0-4781-8f20-330e25403e3f,ba11b63975113ea85400e4fe87083934,252984,released,14,20,13,47,Leiomyosarcoma,LMS,HRD-high
5ecd8d47-e358-4486-bf06-5dbc35d6aa46.htseq.counts,TCGA-FX-A48G,CEEBA881-5A1D-4FDC-8C9D-D60B3FACECF2,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,65,United States,90,0,365,YES,YES,YES,[Not Available],No,No,Consented,2,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],YES,NO,5dd74d20-81cd-4f73-a508-d2865809a10a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A48G,TCGA-FX-A48G-01A,Primary Tumor,5dd74d20-81cd-4f73-a508-d2865809a10a,f2dabfe49ac7cc36d89d08c439dbab77,247039,released,14,18,13,45,Leiomyosarcoma-Uterus,uLMS,HRD-high
5f86524f-b1b9-4511-9f23-3d5b34bb8cf4.htseq.counts,TCGA-DX-AB3B,4DC92923-96EF-4C53-9523-B3D59FF15C4F,Synovial Sarcoma,10,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1583,YES,YES,YES,[Not Available],No,No,Consented,10,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,512bad62-30c5-4f45-94cf-cee2bd315d4f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB3B,TCGA-DX-AB3B-01A,Primary Tumor,512bad62-30c5-4f45-94cf-cee2bd315d4f,1c0b94152bfe2483bffc6cbfad888e47,251278,released,0,0,2,2,Synovial Sarcoma,SS,HRD-low
6003ad34-5914-4ef7-82b4-48be4707265a.htseq.counts,TCGA-DX-A8BH,C852155C-ABFC-4D54-8DD0-136A27508954,Undifferentiated Pleomorphic Sarcoma (UPS),73,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,5,137,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,69,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,c6fef94c-f2ce-483b-bad8-602cac3e05c5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BH,TCGA-DX-A8BH-01A,Primary Tumor,c6fef94c-f2ce-483b-bad8-602cac3e05c5,b6bfdaef3fe8943af8450dd388d8d789,249547,released,11,22,14,47,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
602936ca-5d14-400f-9503-994fcb99a2da.htseq.counts,TCGA-IE-A4EJ,E552F7C5-DDFD-43A0-A35C-7DB138DBD620,Undifferentiated Pleomorphic Sarcoma (UPS),74,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,90,0,125,YES,YES,YES,[Not Available],No,No,Consented,74,[Not Available],Slide,Extremities,[Not Available],[Not Available],[Not Available],NO,NO,a2e6a879-cfa7-4eb1-b62c-a9a368f43215,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IE-A4EJ,TCGA-IE-A4EJ-01A,Primary Tumor,a2e6a879-cfa7-4eb1-b62c-a9a368f43215,2501f6316efa09327b6167280b1356a3,250458,released,9,24,21,54,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
60cacc9e-1213-4974-85b9-92769f24a8bd.htseq.counts,TCGA-IF-A4AK,94C1CB38-5ECA-402D-867B-AB3FE7C30A74,Leiomyosarcoma (LMS),35,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,90,0,657,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,27,[Not Available],NO,Extremities,[Not Available],[Not Available],NO,NO,YES,26afc34e-493c-4a43-9727-fca71126e20b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IF-A4AK,TCGA-IF-A4AK-01A,Primary Tumor,26afc34e-493c-4a43-9727-fca71126e20b,4e508467539a0ffc1f4439f187f3b3bc,253270,released,6,10,12,28,Leiomyosarcoma,LMS,HRD-low
61cce01f-7db5-4a8e-806a-94b1dda47997.htseq.counts,TCGA-LI-A67I,F0A72E67-1BDB-4561-9826-AF117C53BBF2,Myxofibrosarcoma,28,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,2340,United States,85,5,81,YES,YES,YES,[Not Available],No,No,Consented,28,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,ea9b0f94-d26a-49c0-b293-9c88305daad0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-LI-A67I,TCGA-LI-A67I-01A,Primary Tumor,ea9b0f94-d26a-49c0-b293-9c88305daad0,dd80eb05239b6c19755210c973c46d6c,242946,released,14,22,9,45,Myxofibrosarcoma,MFS,HRD-high
61e7d3f1-8e65-4656-b116-c3db81ac09c7.htseq.counts,TCGA-PC-A5DM,F0F372C1-849D-4209-9E50-2C7639626D85,Leiomyosarcoma (LMS),38,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,100,0,2846,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,31,[Not Available],Slide,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,9b52912e-af90-4d61-a589-c7410f55103c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-PC-A5DM,TCGA-PC-A5DM-01A,Primary Tumor,9b52912e-af90-4d61-a589-c7410f55103c,23e266d7acfffd7510434e9a6c028fe1,244419,released,14,29,15,58,Leiomyosarcoma,LMS,HRD-high
637856de-0d05-4cb3-9656-54239d221d21.htseq.counts,TCGA-DX-A23U,ACCB6F23-AEDE-43CB-9C41-3829B52A57E2,Dedifferentiated liposarcoma,82,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,60,0,2939,YES,YES,YES,[Not Available],No,No,Consented,78,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,effa13b3-b851-4f63-8f61-e300bb5eda30,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A23U,TCGA-DX-A23U-01A,Primary Tumor,effa13b3-b851-4f63-8f61-e300bb5eda30,5b35f579d6aa1910afbeb21d83b03da8,247963,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
63c39b0f-2e8f-4ad1-a943-f58f10bd3a49.htseq.counts,TCGA-HS-A5NA,544D66C8-2E7B-4234-AEFD-DEB441E3B28E,Leiomyosarcoma (LMS),-11,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,570,Canada,90,9,955,YES,YES,YES,[Not Available],No,No,Consented,-36,[Not Available],Digital Image,Uterus,[Not Available],[Not Available],[Not Available],NO,NO,033d33b6-1154-4a1a-b0f1-04381c6f99da,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HS-A5NA,TCGA-HS-A5NA-01A,Primary Tumor,033d33b6-1154-4a1a-b0f1-04381c6f99da,8c7686d601e28da8e396ec874274a679,248452,released,10,12,8,30,Leiomyosarcoma-Uterus,uLMS,HRD-low
64cefcc3-5d69-48fc-97b3-73d8451c772b.htseq.counts,TCGA-K1-A6RU,431A0F2F-5CF4-46F5-A32F-60AF3851E969,Myxofibrosarcoma,25,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,570,United States,60,10,135,YES,YES,YES,[Not Available],No,No,Consented,17,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,fe1b41ca-7f28-4647-84cd-c3b5cf96178a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A6RU,TCGA-K1-A6RU-01A,Primary Tumor,fe1b41ca-7f28-4647-84cd-c3b5cf96178a,875680bfc2407b11cc79e9769a9e2c2a,252838,released,4,24,26,54,Myxofibrosarcoma,MFS,HRD-high
659e13ac-f87a-47b6-bcd8-89ccbb91767b.htseq.counts,TCGA-DX-A3LT,32F8354A-7D2F-467B-AFED-E7F91369615F,Dedifferentiated liposarcoma,44,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,239,YES,YES,YES,[Not Available],No,No,Consented,57,[Not Available],NO,Extremities,[Not Available],[Not Available],NO,NO,YES,6fa537b7-6ca2-4b88-a1d2-7afc8719bfe5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3LT,TCGA-DX-A3LT-01A,Primary Tumor,6fa537b7-6ca2-4b88-a1d2-7afc8719bfe5,754a95e5cffadf91f48d69fc6ba541d1,247638,released,7,16,6,29,Dedifferentiated liposarcoma,ddLPS,HRD-low
688d7229-5f79-4aa0-ba42-65be4ff5c574.htseq.counts,TCGA-K1-A3PN,3DB0DE29-F0A6-4CEA-BEC5-22164E795A43,Leiomyosarcoma (LMS),16,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,900,United States,80,2,2003,YES,YES,YES,[Not Available],No,No,Consented,1015,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,7a5ada6e-579d-4d48-86f8-82492c3ce0b4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A3PN,TCGA-K1-A3PN-01A,Primary Tumor,7a5ada6e-579d-4d48-86f8-82492c3ce0b4,7c0a723b37f3a2299b8665eaa6b9e915,252893,released,6,11,3,20,Leiomyosarcoma,LMS,HRD-low
6b765cb3-2593-4776-bdfa-a560bc79ff52.htseq.counts,TCGA-DX-A7ER,A977E30D-4273-45E9-AD1C-E42C10A8F2FD,Synovial Sarcoma,77,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,1687,YES,YES,YES,[Not Available],No,No,Consented,75,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,75633651-dc8e-4b44-9087-4241128202bf,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7ER,TCGA-DX-A7ER-01A,Primary Tumor,75633651-dc8e-4b44-9087-4241128202bf,a5db1cd4689e8266ab943f74e91a3dd8,249714,released,0,0,1,1,Synovial Sarcoma,SS,HRD-low
6c05c035-ef72-4695-bb56-d34adccc2972.htseq.counts,TCGA-DX-A3UA,414E11C3-8430-49A2-B08C-0B496E336CD7,Leiomyosarcoma (LMS),48,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,981,YES,YES,YES,[Not Available],No,No,Consented,44,[Not Available],NO,Extremities,[Not Available],[Not Available],NO,NO,YES,34ff99a3-12d5-4019-be29-fae17a39707b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3UA,TCGA-DX-A3UA-01A,Primary Tumor,34ff99a3-12d5-4019-be29-fae17a39707b,90fa6ddc76cec4b65439eda1d644e5cb,247242,released,7,13,5,25,Leiomyosarcoma,LMS,HRD-low
6dee9288-577c-406d-8268-e7f20ca97ff6.htseq.counts,TCGA-DX-A8BP,7E457156-66D6-4D8C-B159-BE33CA845F58,Undifferentiated Pleomorphic Sarcoma (UPS),35,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1399,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,29,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,d42bcb39-68c7-4dee-bd21-ef54371c5d3a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BP,TCGA-DX-A8BP-01A,Primary Tumor,d42bcb39-68c7-4dee-bd21-ef54371c5d3a,c2e24bb4985fd29f0cadaaaeafb479c1,250029,released,11,15,13,39,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
6e4b3f8b-5ade-45f6-8df3-4274fbfbb3b3.htseq.counts,TCGA-K1-A42W,8C227EF2-2F70-4143-81D9-DE2FB8EF9607,Leiomyosarcoma (LMS),58,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,500,United States,75,0,1085,YES,YES,YES,[Not Available],No,No,Consented,59,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,08a6ea88-5439-45ea-b509-351328eb6a78,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A42W,TCGA-K1-A42W-01A,Primary Tumor,08a6ea88-5439-45ea-b509-351328eb6a78,f2400bccc58f81ab55b14d962af5881c,253757,released,2,7,7,16,Leiomyosarcoma,LMS,HRD-low
6e952a6c-3287-4478-a82d-fea3f36b0a9c.htseq.counts,TCGA-3B-A9I1,06990702-C200-403C-AD6F-5CB78A15BF55,Leiomyosarcoma (LMS),18,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,127,United States,100,5,66,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,c4a1c83b-8bb1-49de-bb4b-f58676e94f84,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9I1,TCGA-3B-A9I1-01A,Primary Tumor,c4a1c83b-8bb1-49de-bb4b-f58676e94f84,bb55f362b7118c81cf9bdea84f10506c,252847,released,7,17,12,36,Leiomyosarcoma-Uterus,uLMS,HRD-low
6ef96fff-361a-4b63-ba94-0c7ae903aa21.htseq.counts,TCGA-DX-AB2J,53FE0909-0DF5-49E3-98EB-296D056370EE,Undifferentiated Pleomorphic Sarcoma (UPS),22,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,20,2788,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,16,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,bb44c76c-7c95-44ff-9eb8-6a4c44ca185c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2J,TCGA-DX-AB2J-01A,Primary Tumor,bb44c76c-7c95-44ff-9eb8-6a4c44ca185c,8efff95436396b4c02e56c6564dcc065,254670,released,5,5,1,11,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
6ff7d442-53d5-4fa8-87fe-52c5cdebf82e.htseq.counts,TCGA-WK-A8XS,BEDF1833-C215-49C8-84FF-49F84C192FFD,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,5,1973,YES,YES,YES,[Not Available],No,No,Consented,-5,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,1a72cfbb-b055-4a7d-b4e4-be8af58f6185,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8XS,TCGA-WK-A8XS-01A,Primary Tumor,1a72cfbb-b055-4a7d-b4e4-be8af58f6185,22524e06d6a4af0b26f072e51c49628b,253556,released,16,22,11,49,Leiomyosarcoma,LMS,HRD-high
715c5cce-5a6b-439b-af4b-c526d609c807.htseq.counts,TCGA-HB-A3YV,3DB6E052-B7C8-4938-870D-E9F68C622A8C,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,811,United States,95,5,72,YES,YES,YES,[Not Available],No,No,Consented,-13,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,YES,NO,aa9ce788-eaec-449a-a59d-14a3b5f1a186,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HB-A3YV,TCGA-HB-A3YV-01A,Primary Tumor,aa9ce788-eaec-449a-a59d-14a3b5f1a186,888114a2ba1314e3d97910c20dcbb9e3,255074,released,8,26,14,48,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
7334f65f-fc88-4083-a9a8-8b67fd48055a.htseq.counts,TCGA-DX-AB2X,855F843C-4FAD-46D8-B3C0-4CD45C6998DF,Undifferentiated Pleomorphic Sarcoma (UPS),58,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,5,1171,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,55,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,aa77c0a2-651c-47f8-b8d3-f823d42ac73e,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2X,TCGA-DX-AB2X-01A,Primary Tumor,aa77c0a2-651c-47f8-b8d3-f823d42ac73e,b83560fd6dee75343c00ce4f5c654e35,246511,released,17,23,13,53,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
745c3596-110d-4c3e-9a68-b0c9b50f57cb.htseq.counts,TCGA-DX-A6YS,1ECBAB38-1736-465C-9EE2-BF39706C9663,Myxofibrosarcoma,20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1751,YES,YES,YES,[Not Available],No,No,Consented,13,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,84d9cc58-8cf1-46d0-b55e-dda39b92c759,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YS,TCGA-DX-A6YS-01A,Primary Tumor,84d9cc58-8cf1-46d0-b55e-dda39b92c759,e5892fb9b7eec77804d9531f44346b8f,254769,released,11,28,21,60,Myxofibrosarcoma,MFS,HRD-high
75d5228b-4504-492c-baf1-185cde42d94a.htseq.counts,TCGA-QQ-A5V9,20EE01D8-EC14-45F8-A347-A36434FA13B3,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,370,United States,80,0,4895,YES,YES,YES,[Not Available],No,No,Deceased,[Not Available],[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,4dd79f21-257a-4a05-a10e-d10910537de7,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A5V9,TCGA-QQ-A5V9-01A,Primary Tumor,4dd79f21-257a-4a05-a10e-d10910537de7,6a3c6eefe3cfae2fe3ecdad253d47e35,250427,released,11,29,10,50,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
79e3e281-3dcc-4256-b412-5992fff62ed1.htseq.counts,TCGA-DX-AB2Z,CAE57E14-ACA3-4C70-9EE2-6C786DC87C5A,Undifferentiated Pleomorphic Sarcoma (UPS),25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,5,1092,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,6d99b7a9-fc56-4a7c-9d9d-65bfecb23da1,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2Z,TCGA-DX-AB2Z-01A,Primary Tumor,6d99b7a9-fc56-4a7c-9d9d-65bfecb23da1,f06e8c613f00857c085176309b14b096,251367,released,8,29,26,63,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
7b89d5ea-483a-486d-9cf0-d6c735b8178c.htseq.counts,TCGA-DX-A8BN,68F4A859-0BE5-4E3F-898E-BCB9BD1B3827,Undifferentiated Pleomorphic Sarcoma (UPS),8,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,889,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,9dfbd59b-8618-49a7-9c65-d770403971a6,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BN,TCGA-DX-A8BN-01A,Primary Tumor,9dfbd59b-8618-49a7-9c65-d770403971a6,f0b8902104f2e30a3306c3256a296bf3,247766,released,11,20,13,44,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
7c218e43-3d91-466d-9966-15704525ba44.htseq.counts,TCGA-DX-A6BH,39F40E6D-2014-4066-A0DB-61DCD0029B57,Dedifferentiated liposarcoma,35,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,269,YES,YES,YES,[Not Available],No,No,Consented,16,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,1e45da1f-20d6-455c-b493-162cc91d2f19,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6BH,TCGA-DX-A6BH-01A,Primary Tumor,1e45da1f-20d6-455c-b493-162cc91d2f19,fe9e63a73d5999c2606b32b05b6d6e26,249651,released,2,1,0,3,Dedifferentiated liposarcoma,ddLPS,HRD-low
7d7fcb4a-62ca-4e45-93d0-271f4c299c98.htseq.counts,TCGA-DX-A6YU,016886F1-1B40-422E-82CB-51307FCA8CD4,Myxofibrosarcoma,34,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,10,450,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,23,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,b9cb388a-5b9b-4b98-884e-a6794ab3388f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YU,TCGA-DX-A6YU-01A,Primary Tumor,b9cb388a-5b9b-4b98-884e-a6794ab3388f,c1731b22b3b9583ecce0d21b0618ec51,255823,released,25,20,17,62,Myxofibrosarcoma,MFS,HRD-high
7f989e2c-1327-4a34-92b7-f3ace483cbc6.htseq.counts,TCGA-IF-A4AJ,86AE3E79-5C03-480F-8A5A-35BAC00CB89D,Leiomyosarcoma (LMS),20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,90,0,3403,YES,YES,YES,[Not Available],No,No,Deceased,[Not Available],[Not Available],NO,Extremities,[Not Available],[Not Available],NO,NO,YES,c003334e-9202-4bf1-a764-d93d4009e899,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IF-A4AJ,TCGA-IF-A4AJ-01A,Primary Tumor,c003334e-9202-4bf1-a764-d93d4009e899,85e404049cdfe37ae1d22c6ecb83ded6,253049,released,8,15,6,29,Leiomyosarcoma,LMS,HRD-low
803682f7-89c0-446c-87d4-c86131ad8e4b.htseq.counts,TCGA-JV-A75J,ED0E5F9D-7DF8-4AF8-9916-D30139A9B807,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,55,United States,80,5,74,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,d8aa9a99-c9fe-4b73-8074-e00439ef359f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-JV-A75J,TCGA-JV-A75J-01A,Primary Tumor,d8aa9a99-c9fe-4b73-8074-e00439ef359f,932cd9fc9461011a5184fefad660e893,253044,released,8,13,3,24,Leiomyosarcoma-Uterus,uLMS,HRD-low
80a6614a-d8d3-4ae3-a9c3-42e722d6782a.htseq.counts,TCGA-DX-A3U7,910CD9B0-5BBE-47E5-8F4C-A6E8AA580281,Leiomyosarcoma (LMS),32,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,915,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Extremities,[Not Available],[Not Available],NO,NO,YES,2779c6f1-a12f-4a6f-8625-3feeff46026a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3U7,TCGA-DX-A3U7-01A,Primary Tumor,2779c6f1-a12f-4a6f-8625-3feeff46026a,19cc0855e2d531d1ee7c8b350459a7f1,252156,released,14,25,16,55,Leiomyosarcoma,LMS,HRD-high
81cab804-bfb1-44f0-ac2d-923e0766ac61.htseq.counts,TCGA-DX-A3U5,FB5C61D6-717E-4798-8306-86EB196D5609,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,93,YES,YES,YES,[Not Available],No,No,Consented,-4,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,0934a0b3-858d-430c-a5c9-ea459104a392,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3U5,TCGA-DX-A3U5-01A,Primary Tumor,0934a0b3-858d-430c-a5c9-ea459104a392,5cbfed753ee5073d3a8fcd68818ed0a1,249298,released,7,19,13,39,Dedifferentiated liposarcoma,ddLPS,HRD-low
836e295d-d1e1-48f1-98c8-04d649fbd796.htseq.counts,TCGA-DX-A240,8ACAF190-5A0D-440C-9C9A-B9EABDF661BE,Dedifferentiated liposarcoma,18,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,60,0,1699,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Other,Other,Visceral- Genitourinary,[Not Available],NO,YES,8933b4cd-a681-4545-9602-edc8ab22ae3f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A240,TCGA-DX-A240-01A,Primary Tumor,8933b4cd-a681-4545-9602-edc8ab22ae3f,82e30203978502418d0666085781925d,248819,released,0,1,0,1,Dedifferentiated liposarcoma,ddLPS,HRD-low
84c9f592-65bc-4b55-9064-3c499584c39c.htseq.counts,TCGA-HB-A2OT,C9B51F86-B26B-4329-BB28-A1298D9B7142,Undifferentiated Pleomorphic Sarcoma (UPS),28,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,308,United States,70,20,741,YES,YES,YES,[Not Available],No,No,Consented,12,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],YES,NO,8de5b854-bebc-4579-b8b4-e282cc11f805,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HB-A2OT,TCGA-HB-A2OT-01A,Primary Tumor,8de5b854-bebc-4579-b8b4-e282cc11f805,c193d8acc6bf3bb18610c7861e53079c,248911,released,16,17,16,49,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
8583bc3e-f4ee-4364-b77a-2026c9a88a91.htseq.counts,TCGA-FX-A3TO,784F6B88-9046-4FFF-B061-81EE0BB27392,Undifferentiated Pleomorphic Sarcoma (UPS),10,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,255,United States,80,0,56,YES,YES,YES,[Not Available],No,No,Consented,10,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,YES,NO,ea806749-e136-4d0e-ad1d-364603a3e041,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A3TO,TCGA-FX-A3TO-01A,Primary Tumor,ea806749-e136-4d0e-ad1d-364603a3e041,894f0b665239c710ae3525e5816d4c38,251367,released,6,35,21,62,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
8956daaf-3d12-4214-9f51-e5e8f32cbb66.htseq.counts,TCGA-DX-A48R,8549C8FA-EF3E-451A-8D20-F13249D8CC47,Leiomyosarcoma (LMS),102,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,10,3576,YES,YES,YES,[Not Available],No,No,Consented,98,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,5e1a4179-0aea-4d5d-83ae-d74dfb6f733e,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48R,TCGA-DX-A48R-01A,Primary Tumor,5e1a4179-0aea-4d5d-83ae-d74dfb6f733e,5355f4dc65253f730daac3129b76bfce,254507,released,10,18,12,40,Leiomyosarcoma,LMS,HRD-low
8a6dee54-4a20-4901-a5c5-2dd7689241b6.htseq.counts,TCGA-WK-A8XX,0BB1B503-FAE2-4B9D-9709-25FD66194E8D,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,0,2258,YES,YES,YES,[Not Available],No,No,Consented,-8,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,c575434b-9f05-4e07-917a-114b8f8428e4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8XX,TCGA-WK-A8XX-01A,Primary Tumor,c575434b-9f05-4e07-917a-114b8f8428e4,55ecad0d36b8b13a601edf900fb230f7,257419,released,8,17,14,39,Leiomyosarcoma,LMS,HRD-low
8b31cb46-6a40-4516-b21b-611339bdb4c6.htseq.counts,TCGA-IE-A6BZ,D22369D7-9F7A-4E54-BADC-6C800EEB7E4C,Undifferentiated Pleomorphic Sarcoma (UPS),28,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,230,United States,50,0,65,NO,YES,YES,[Not Available],No,No,Consented,28,[Not Available],Slide,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,NO,1fe41d87-34e5-4eaf-8c4a-97c9d8dca1b9,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IE-A6BZ,TCGA-IE-A6BZ-01A,Primary Tumor,1fe41d87-34e5-4eaf-8c4a-97c9d8dca1b9,2d15b5277adf3e2dcd704b05db6fe5cb,248341,released,8,18,22,48,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
8b82feac-4c40-4408-b13a-1a8a5830c200.htseq.counts,TCGA-KF-A41W,A60B467B-E29D-4AC0-A221-DAE30011A183,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,1077,United States,90,10,75,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,4e9b700a-89a8-4a14-a573-d3f8a2bfbf9f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-KF-A41W,TCGA-KF-A41W-01A,Primary Tumor,4e9b700a-89a8-4a14-a573-d3f8a2bfbf9f,0b158d90ef54f21a6dd408e928225643,244239,released,19,25,13,57,Leiomyosarcoma-Uterus,uLMS,HRD-high
8c2c4cb7-66e4-4725-ae4b-73c5ed0e11d1.htseq.counts,TCGA-DX-A7ET,8CB1EBB2-30E4-4CC8-A221-9BCF1867176B,Undifferentiated Pleomorphic Sarcoma (UPS),14,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,32,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,10,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,78bf5b69-8ac6-4676-b179-2a871635f75a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7ET,TCGA-DX-A7ET-01A,Primary Tumor,78bf5b69-8ac6-4676-b179-2a871635f75a,d7072e5252522bec7729b6ec0d480642,248177,released,23,29,9,61,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
8de65d94-798f-43d9-93bb-e27680374903.htseq.counts,TCGA-DX-A48N,5E76FE5B-24DC-4605-A5DC-5E06DD8620E4,Dedifferentiated liposarcoma,27,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,70,0,128,YES,YES,YES,[Not Available],No,No,Consented,16,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,e8a3539e-ab8f-4b93-9c15-01cbf6688357,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48N,TCGA-DX-A48N-01A,Primary Tumor,e8a3539e-ab8f-4b93-9c15-01cbf6688357,3acc21d48cec4e6ce89290316eb1588b,255048,released,4,19,10,33,Dedifferentiated liposarcoma,ddLPS,HRD-low
8deb82da-0278-447d-90ed-cad8474c4dd5.htseq.counts,TCGA-X6-A8C4,EA02C527-63BD-4793-98C3-86025D2BF13D,Undifferentiated Pleomorphic Sarcoma (UPS),8,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,250,United States,95,0,51,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,07e8ebf9-a2ca-4101-90ef-63dbec122eab,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A8C4,TCGA-X6-A8C4-01A,Primary Tumor,07e8ebf9-a2ca-4101-90ef-63dbec122eab,b839302056a28b4c227b5d91d11506dc,250690,released,21,27,28,76,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
8ed2e52f-20b9-4cd1-9d6f-61a56a040504.htseq.counts,TCGA-MB-A8JL,659DB59D-9D59-457A-A857-DD73E18A17A4,Leiomyosarcoma (LMS),25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,320,United States,90,5,25,YES,YES,YES,[Not Available],No,No,Consented,25,[Not Available],Slide,Chest,[Not Available],[Not Available],[Not Available],NO,YES,81038aa6-3603-4680-bece-e9b03da4a022,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MB-A8JL,TCGA-MB-A8JL-01A,Primary Tumor,81038aa6-3603-4680-bece-e9b03da4a022,c7805c59092f8340ad9327babf0c7e33,250592,released,4,8,2,14,Leiomyosarcoma,LMS,HRD-low
91d1ff70-3a8c-4d3a-91e6-e2579d9ec53e.htseq.counts,TCGA-DX-A7EN,AB26B1F4-9062-49E4-B121-28D5F7FC61B6,Leiomyosarcoma (LMS),16,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,219,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,22009a9a-f16b-4d58-98ec-41b5c31a05ba,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7EN,TCGA-DX-A7EN-01A,Primary Tumor,22009a9a-f16b-4d58-98ec-41b5c31a05ba,a1b45b15e599b949d1c92947b2531982,254526,released,6,6,6,18,Leiomyosarcoma,LMS,HRD-low
9235a5b1-2a3b-448b-91c5-59c92180c66f.htseq.counts,TCGA-3B-A9HP,64DB482B-943A-42F4-9AF9-03D1704CD9DA,Leiomyosarcoma (LMS),50,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,71,United States,100,15,225,YES,YES,YES,[Not Available],No,No,Consented,29,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,5a65dfb0-dfe8-409a-9f69-6422be7fbbe4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HP,TCGA-3B-A9HP-01A,Primary Tumor,5a65dfb0-dfe8-409a-9f69-6422be7fbbe4,45026258818732b5abcc2b3c5a616831,252037,released,3,6,1,10,Leiomyosarcoma,LMS,HRD-low
9281e319-2c83-470b-89e5-876d2ada2c82.htseq.counts,TCGA-DX-A6BA,42A7C11E-04E9-4403-9BA9-9DD44B77C90F,Leiomyosarcoma (LMS),56,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,1701,YES,YES,YES,[Not Available],No,No,Consented,37,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,63f20773-d696-40ca-9506-11f5da1fc37b,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6BA,TCGA-DX-A6BA-01A,Primary Tumor,63f20773-d696-40ca-9506-11f5da1fc37b,265ce50718e535e739a59062a6c804a4,251815,released,8,16,10,34,Leiomyosarcoma,LMS,HRD-low
93d76b56-2660-46b7-acfd-0afc04ec7901.htseq.counts,TCGA-IE-A4EH,988185CF-A54C-4335-A4AB-F59CE3A470EA,Leiomyosarcoma (LMS),314,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,90,0,342,YES,YES,YES,[Not Available],"Yes, History of Synchronous/Bilateral Malignancy",No,Consented,314,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,NO,78d672bc-25f5-44fe-986f-d968f985b1a8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IE-A4EH,TCGA-IE-A4EH-01A,Primary Tumor,78d672bc-25f5-44fe-986f-d968f985b1a8,1750ed06b85ff954f0d8bffda151644b,249148,released,11,15,8,34,Leiomyosarcoma-Uterus,uLMS,HRD-low
94eaf79f-14e8-421a-ba4f-e2f1fbae2592.htseq.counts,TCGA-DX-AB35,E7EA9645-A60B-4B94-8746-31A7377687C4,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,457,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,-39,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,39fd88f3-ce90-434b-a1ca-f125e7f8a3f8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB35,TCGA-DX-AB35-01A,Primary Tumor,39fd88f3-ce90-434b-a1ca-f125e7f8a3f8,13330c9f87670fe034aa7dfb850c616b,246775,released,3,26,15,44,Dedifferentiated liposarcoma,ddLPS,HRD-high
951db72b-e8ae-45bb-9a2b-3ba452b9e111.htseq.counts,TCGA-WP-A9GB,4DF7599A-680C-452A-B472-2370B8F190A5,Leiomyosarcoma (LMS),31,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,376,United States,90,5,610,YES,YES,YES,[Not Available],No,No,Consented,31,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,19bd2173-2e51-485e-9820-f469628fe184,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WP-A9GB,TCGA-WP-A9GB-01A,Primary Tumor,19bd2173-2e51-485e-9820-f469628fe184,7ed6609a64c3d6f29c08d1cebd3f8d11,254797,released,15,18,29,62,Leiomyosarcoma-Uterus,uLMS,HRD-high
96dad694-4821-4935-85e3-0fbd7c694c22.htseq.counts,TCGA-LI-A9QH,C3C63AF2-7525-46B9-BD01-8509F3C081F8,Undifferentiated Pleomorphic Sarcoma (UPS),28,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,2500,United States,85,15,39,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,28,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,68720bab-013c-47d2-b395-eaef1bc7f4fc,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-LI-A9QH,TCGA-LI-A9QH-01A,Primary Tumor,68720bab-013c-47d2-b395-eaef1bc7f4fc,e8fc355ecc2d3376126c0fbabb1c546d,248727,released,13,33,14,60,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
98b10baf-a8e5-4269-a31c-a151737b3d5e.htseq.counts,TCGA-JV-A5VE,7328589C-0287-4784-83A6-4BD0CD072D1C,Leiomyosarcoma (LMS),0,YES,Incisional Biopsy,[Not Applicable],[Not Applicable],Cryovial,YES,184,United States,95,0,20,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,c86b0470-0a79-4411-84ac-d404a0947049,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-JV-A5VE,TCGA-JV-A5VE-01A,Primary Tumor,c86b0470-0a79-4411-84ac-d404a0947049,c99ebba80c8f0db62651ef5bab02ad14,252630,released,14,18,9,41,Leiomyosarcoma-Uterus,uLMS,HRD-low
99767239-d39b-471a-bd5d-5e36c38d8de7.htseq.counts,TCGA-DX-A8BU,F53143DE-2704-4638-94E2-3661C1DBB3B9,Undifferentiated Pleomorphic Sarcoma (UPS),10,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,2817,YES,YES,YES,[Not Available],No,No,Consented,4,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,3aef6053-29e6-49da-9b31-3567972bc395,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BU,TCGA-DX-A8BU-01A,Primary Tumor,3aef6053-29e6-49da-9b31-3567972bc395,5d8c47a8ea9e996bd4bcb59c6cfcac22,250947,released,12,23,27,62,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
99d85253-ed16-4f0d-a4d9-3a4c1c3675df.htseq.counts,TCGA-DX-A8BJ,A868D01C-7148-418A-B36C-808DBC7E068D,Undifferentiated Pleomorphic Sarcoma (UPS),47,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,896,YES,YES,YES,[Not Available],No,No,Consented,36,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,4898f1d5-5402-4fce-9f2b-7b75dde43e59,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BJ,TCGA-DX-A8BJ-01A,Primary Tumor,4898f1d5-5402-4fce-9f2b-7b75dde43e59,11ec8a106d4130bb5cda7184022bffd6,246833,released,4,21,13,38,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
99d8734f-3372-40ae-a7a3-eb092c8b7e47.htseq.counts,TCGA-DX-A3UF,A612B7DA-1DDD-4A92-8D9A-674F26F98D8A,Leiomyosarcoma (LMS),704,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,1573,YES,YES,YES,[Not Available],No,No,Consented,693,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,9f2b96c0-1483-49a7-94ee-d7e73b25148a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3UF,TCGA-DX-A3UF-01A,Primary Tumor,9f2b96c0-1483-49a7-94ee-d7e73b25148a,2dc29ed70d2ac58c678413852cac305c,252674,released,15,15,15,45,Leiomyosarcoma,LMS,HRD-high
9a2b0bc5-8882-4aba-ac8a-51b1484b66ea.htseq.counts,TCGA-SI-AA8C,E8EA3D4D-36E5-460F-A0CF-0F40D9BB0C8F,Malignant Peripheral Nerve Sheath Tumors (MPNST),0,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,850,United States,98,30,217,YES,YES,YES,[Not Available],No,No,Consented,-6,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,bec13ddf-514e-4a1c-ae22-4f592ba94859,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SI-AA8C,TCGA-SI-AA8C-01A,Primary Tumor,bec13ddf-514e-4a1c-ae22-4f592ba94859,683a369d4963a40b88e4b13ac4d0f1a9,256048,released,11,15,7,33,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
9b848ce5-b30e-4aa3-96f7-a1cea36d28ff.htseq.counts,TCGA-DX-A48J,40FC700C-6348-4FB6-88EA-95E5B61196B2,Leiomyosarcoma (LMS),32,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,3324,YES,YES,YES,[Not Available],No,No,Consented,28,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,3cb7554e-21fa-4786-93eb-b5c081c7f607,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48J,TCGA-DX-A48J-01A,Primary Tumor,3cb7554e-21fa-4786-93eb-b5c081c7f607,ad89a124bd257591856edbec1c7df93e,254996,released,7,4,8,19,Leiomyosarcoma,LMS,HRD-low
9b9e9ba2-f934-40a2-a312-d876707c37d2.htseq.counts,TCGA-DX-A7EI,80690D38-0D5C-4F52-8AAD-110769F818C3,Dedifferentiated liposarcoma,48,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,3845,YES,YES,YES,[Not Available],No,No,Consented,828,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,47d122ec-2632-4047-b415-32ac2825bd45,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7EI,TCGA-DX-A7EI-01A,Primary Tumor,47d122ec-2632-4047-b415-32ac2825bd45,ccd6e873057d2b19da14a5116dff923b,258423,released,10,18,5,33,Dedifferentiated liposarcoma,ddLPS,HRD-low
9cce0948-dc14-46e0-bc57-16dfff825ffa.htseq.counts,TCGA-DX-A8BR,01D4C0B5-BA01-4672-82F0-66A7BD5D0073,Undifferentiated Pleomorphic Sarcoma (UPS),13,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,4026,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,4681b23d-077e-4317-ac7d-6cc0d784d5e3,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BR,TCGA-DX-A8BR-01A,Primary Tumor,4681b23d-077e-4317-ac7d-6cc0d784d5e3,aaf5fa38a87c039d53ba1f340a18d76d,249083,released,14,12,16,42,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
9d0f2ef4-001d-4f57-bea3-76a27002f7a1.htseq.counts,TCGA-FX-A3NJ,29FDA349-D725-4F69-BB11-95D5454400F4,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,285,United States,80,0,38,YES,YES,YES,[Not Available],No,No,Consented,3,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,YES,NO,0fbdcf5e-52b6-4c44-b251-e43eef9da5f3,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A3NJ,TCGA-FX-A3NJ-01A,Primary Tumor,0fbdcf5e-52b6-4c44-b251-e43eef9da5f3,37c43016a47eb214c4d4e16fdf095672,250522,released,4,5,4,13,Leiomyosarcoma,LMS,HRD-low
9de09e52-733b-4584-8916-04686c769860.htseq.counts,TCGA-DX-A1L4,EEF3D5DB-7C19-4CEA-947B-9DE9ED331A72,Dedifferentiated liposarcoma,6,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,637,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,8b68dc1b-d9d0-4673-a9e2-011ca559afa2,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1L4,TCGA-DX-A1L4-01A,Primary Tumor,8b68dc1b-d9d0-4673-a9e2-011ca559afa2,7e8c547a7c8338f048f4281bd246b8f0,244656,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
9e934785-7b65-4528-8f5e-f36268511c02.htseq.counts,TCGA-DX-AB2Q,E4A19B22-CED3-4123-863D-2CDE750226EE,Undifferentiated Pleomorphic Sarcoma (UPS),12,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1652,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,7d3ae198-e9af-4e95-9af4-5d1a06eacea3,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2Q,TCGA-DX-AB2Q-01A,Primary Tumor,7d3ae198-e9af-4e95-9af4-5d1a06eacea3,a65b96ef5f84378a46bcc0d62720f4b9,251448,released,20,33,17,70,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
9ebd5d5a-1893-4ea6-8944-85c6981b1fba.htseq.counts,TCGA-DX-A8BK,3328FB12-BF55-4F73-87E8-902249996A62,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,1527,YES,YES,YES,[Not Available],No,No,Consented,-8,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,a8ececd6-421e-411c-9ba2-bc2e9729d6ce,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BK,TCGA-DX-A8BK-01A,Primary Tumor,a8ececd6-421e-411c-9ba2-bc2e9729d6ce,75681f0831143fc9cde239fa5d397de9,246743,released,6,21,23,50,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
9ee18371-3878-4bee-829b-5469d68c5b53.htseq.counts,TCGA-SG-A849,926C06E9-448D-44C2-BE23-D3B62CC14C6B,Undifferentiated Pleomorphic Sarcoma (UPS),16,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,67,United States,90,10,37,YES,YES,YES,[Not Available],"Yes, History of Synchronous/Bilateral Malignancy",No,Consented,9,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,2132a5d7-8947-43ea-957c-6e2afc83ac1e,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SG-A849,TCGA-SG-A849-01A,Primary Tumor,2132a5d7-8947-43ea-957c-6e2afc83ac1e,e1fc7d0477bb57c3e2a092fa986db48e,253378,released,13,23,20,56,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
9ff7df7f-e222-4094-8455-bc5f25522bee.htseq.counts,TCGA-DX-A1KZ,61D4DFF3-DB42-43CF-A8C4-72CB4719D7BE,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,445,YES,YES,YES,[Not Available],No,No,Consented,-4,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,08a1d54a-c461-4127-ba93-9172ebf7ada8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1KZ,TCGA-DX-A1KZ-01A,Primary Tumor,08a1d54a-c461-4127-ba93-9172ebf7ada8,7112b8c2fab500bb8bbd3eb8eaf3292d,247924,released,1,20,12,33,Dedifferentiated liposarcoma,ddLPS,HRD-low
a0e4b8ba-2413-4ef5-a960-2348b3ac8170.htseq.counts,TCGA-HB-A5W3,E7E97623-5C8A-42B4-ABC6-E7B424816713,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,604,United States,70,0,943,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,-2,[Not Available],Digital Image,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,NO,0a12f33e-e7fb-4889-97cc-2a61a97c7ae7,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HB-A5W3,TCGA-HB-A5W3-01A,Primary Tumor,0a12f33e-e7fb-4889-97cc-2a61a97c7ae7,b221db0cc4268116355460dd47d3a887,252117,released,13,15,8,36,Leiomyosarcoma,LMS,HRD-low
a149691d-5177-478c-bb71-a7dd84ea17bb.htseq.counts,TCGA-Z4-AAPG,F7E730B2-BE2B-4B47-8A55-2C888758ED6A,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,220,Russia,90,0,215,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,94c524e1-fb71-485e-9e2b-52b69a6ebbdc,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-Z4-AAPG,TCGA-Z4-AAPG-01A,Primary Tumor,94c524e1-fb71-485e-9e2b-52b69a6ebbdc,6606675595b3ddb4200639cebcb7c0bd,249924,released,16,22,12,50,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
a1df1f8a-12b7-40d2-bf62-7d5a8cdbf4f2.htseq.counts,TCGA-PC-A5DN,784414B9-1F18-4C31-A062-6E5048482E78,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,100,5,2625,YES,YES,YES,[Not Available],No,No,Consented,-1,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,7ed3e379-7d0f-458c-bb1c-b909fe496cb0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-PC-A5DN,TCGA-PC-A5DN-01A,Primary Tumor,7ed3e379-7d0f-458c-bb1c-b909fe496cb0,38504193e01a3cae0a904fbb2727ff3c,253698,released,3,3,2,8,Leiomyosarcoma,LMS,HRD-low
a4dc7ee0-02b0-4c6f-8b90-894d337d638b.htseq.counts,TCGA-HS-A5N7,3D257887-D0F2-40D1-945B-A46DB90E63DF,Leiomyosarcoma (LMS),-33,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,405,Canada,90,9,362,YES,YES,YES,[Not Available],No,No,Consented,57,[Not Available],Digital Image,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,NO,1e6e48d6-74c6-42ae-a9c5-e0fdf640a510,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HS-A5N7,TCGA-HS-A5N7-01A,Primary Tumor,1e6e48d6-74c6-42ae-a9c5-e0fdf640a510,f43f630e7d1b3f67b1ee068e41b14461,253169,released,10,11,4,25,Leiomyosarcoma,LMS,HRD-low
a52e728c-c352-4fd7-8f3c-fe0fbf2854d0.htseq.counts,TCGA-IE-A4EI,1FE30A2F-22A6-4F88-9A3A-7A11359CC151,Leiomyosarcoma (LMS),20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,640,United States,95,0,85,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],Slide,Extremities,[Not Available],[Not Available],[Not Available],NO,NO,1275efd6-83e7-44a4-85a5-bdf44fb0d2c5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IE-A4EI,TCGA-IE-A4EI-01A,Primary Tumor,1275efd6-83e7-44a4-85a5-bdf44fb0d2c5,c49299f1a6ba7b5cafbfaec289e6017e,251176,released,7,13,9,29,Leiomyosarcoma,LMS,HRD-low
a6574ca4-07a2-43cd-a604-e737a249247f.htseq.counts,TCGA-DX-A1L0,87E0C11A-CF75-4877-B4C8-23AA36631B4F,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,1121,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,4ed89b95-4292-482c-8550-2bbb1dbf6763,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1L0,TCGA-DX-A1L0-01A,Primary Tumor,4ed89b95-4292-482c-8550-2bbb1dbf6763,e994f0bf106ad5b6ef2408d44b71377f,249417,released,8,25,17,50,Dedifferentiated liposarcoma,ddLPS,HRD-high
a6ac2caa-ba71-4520-a36e-6e790f468165.htseq.counts,TCGA-KD-A5QT,586F6A69-FCB9-422F-B71E-AA8B2354694F,Leiomyosarcoma (LMS),0,YES,"Other Method, specify",MRH/BSO,[Not Applicable],Cryovial,YES,100,United States,90,0,861,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,6bc8c44b-de7a-44e5-a1d2-94b68f146bee,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-KD-A5QT,TCGA-KD-A5QT-01A,Primary Tumor,6bc8c44b-de7a-44e5-a1d2-94b68f146bee,8c94743d326dd57439d32ad9d030c020,250926,released,7,10,8,25,Leiomyosarcoma-Uterus,uLMS,HRD-low
a83fc4d2-aad3-401c-820a-cd4519032be0.htseq.counts,TCGA-IW-A3M5,34B60937-76B3-401C-A8DD-3F78E2B20A38,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,150,United States,95,5,364,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,5d8422df-2388-4118-963e-6cc7538f2e6f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IW-A3M5,TCGA-IW-A3M5-01A,Primary Tumor,5d8422df-2388-4118-963e-6cc7538f2e6f,8df181b9a75a2b07d25e9bba33b1ccb0,250295,released,7,24,7,38,Leiomyosarcoma-Uterus,uLMS,HRD-low
a9239277-f8ef-4b70-916d-1d9ac149bbcf.htseq.counts,TCGA-K1-A42X,F64F2F08-7F2A-44A2-A1A6-90A77DC43D06,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,400,United States,90,0,3155,YES,YES,YES,[Not Available],No,No,Consented,2048,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,64012440-3649-411e-a35f-b6026262a207,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A42X,TCGA-K1-A42X-01A,Primary Tumor,64012440-3649-411e-a35f-b6026262a207,49cfeca371bc4374f552ed696d34673d,253556,released,11,12,12,35,Leiomyosarcoma,LMS,HRD-low
a9984029-887a-4215-a013-5ce599588ba5.htseq.counts,TCGA-IS-A3K7,7254C2AC-D8AC-4D6E-B444-4CB5F8A6EB36,Leiomyosarcoma (LMS),30,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cassette,YES,200,United States,99,0,3999,YES,YES,YES,[Not Available],No,No,Consented,28,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,e59e6cff-ec31-4284-b63b-bdf81a0477e1,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IS-A3K7,TCGA-IS-A3K7-01A,Primary Tumor,e59e6cff-ec31-4284-b63b-bdf81a0477e1,82ea05f911e984884c925fffef5f94d8,249722,released,15,12,10,37,Leiomyosarcoma-Uterus,uLMS,HRD-low
aa9abdc3-7273-44fa-888f-801323c6f3cf.htseq.counts,TCGA-DX-A7ES,394668DF-AA2A-46CB-90D4-0F830AD91278,Dedifferentiated liposarcoma,35,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,72,YES,YES,YES,[Not Available],No,No,Consented,15,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,5b2cf105-ce05-4a20-abc0-67a528639ccd,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7ES,TCGA-DX-A7ES-01A,Primary Tumor,5b2cf105-ce05-4a20-abc0-67a528639ccd,fc062a255a0fc135b9892efc6415936d,248048,released,0,0,1,1,Dedifferentiated liposarcoma,ddLPS,HRD-low
ab0509d5-0bcb-42bb-9b0f-c7a9b1eadfe7.htseq.counts,TCGA-PC-A5DP,30C8F2C5-9AAC-4C5B-B621-31E6C5F3C84D,Leiomyosarcoma (LMS),15,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,100,0,2006,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,10,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,75af648c-8ec4-4385-b8b2-42da30a2bc48,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-PC-A5DP,TCGA-PC-A5DP-01A,Primary Tumor,75af648c-8ec4-4385-b8b2-42da30a2bc48,b9caf8a1e98a2eec742570a463dc411c,252029,released,7,18,15,40,Leiomyosarcoma,LMS,HRD-low
ad498bd4-34ac-4eef-8f8d-4e0cd1561bc1.htseq.counts,TCGA-DX-A3LW,E25B5088-A3D4-4F3C-8335-308C571F6A30,Dedifferentiated liposarcoma,8,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,70,0,2799,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,3dce19d1-bb64-45e4-a535-b673d1fb13a5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3LW,TCGA-DX-A3LW-01A,Primary Tumor,3dce19d1-bb64-45e4-a535-b673d1fb13a5,6d9d18627510fc86e181cfe0f36aa6e0,250462,released,4,12,7,23,Dedifferentiated liposarcoma,ddLPS,HRD-low
ae36ca5c-e1eb-4a54-a90a-7d69a13fcbbb.htseq.counts,TCGA-3B-A9HI,84ABF456-CE66-4930-BF43-33141447CE5F,Dedifferentiated liposarcoma,9,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,128,United States,90,0,70,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,dde6619c-ab39-4b52-931d-4673d7528de9,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HI,TCGA-3B-A9HI-01A,Primary Tumor,dde6619c-ab39-4b52-931d-4673d7528de9,3600b6ce959fb0349b634d1cfb8b27f9,246131,released,10,16,18,44,Dedifferentiated liposarcoma,ddLPS,HRD-high
af1619c5-6441-4cf7-bb16-cd2be1473e5d.htseq.counts,TCGA-KD-A5QU,52254562-F812-4023-BB00-55E2D766EADB,Leiomyosarcoma (LMS),37,YES,"Other Method, specify",TAH/BSO,[Not Applicable],Cryovial,YES,100,United States,99,0,699,YES,YES,YES,[Not Available],No,No,Consented,37,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,ff5c13bd-f0c2-4dc4-8554-0bf90bc6b144,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-KD-A5QU,TCGA-KD-A5QU-01A,Primary Tumor,ff5c13bd-f0c2-4dc4-8554-0bf90bc6b144,d4ea4751db7c3ac9d2d15446240643f3,254741,released,7,16,16,39,Leiomyosarcoma-Uterus,uLMS,HRD-low
b0322292-c63d-4f22-8b9a-4f4adba47ae3.htseq.counts,TCGA-IW-A3M6,BCAEA097-8911-4503-8AF9-E7E0515D1529,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,5,189,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,97729b96-026a-4679-8d9f-4b989a6e0ecf,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IW-A3M6,TCGA-IW-A3M6-01A,Primary Tumor,97729b96-026a-4679-8d9f-4b989a6e0ecf,204a766b9503174b4a499e1c5e6e2808,250658,released,15,20,21,56,Leiomyosarcoma-Uterus,uLMS,HRD-high
b1623bef-8502-4c84-ae87-7d0dd1c4994f.htseq.counts,TCGA-WK-A8XQ,ADBABADE-22E7-4FD1-B444-9B4BE35D9B8E,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,0,1635,YES,YES,YES,[Not Available],No,No,Consented,-3,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,a3b8ad22-998e-40a9-acd1-d39dbdffc107,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8XQ,TCGA-WK-A8XQ-01A,Primary Tumor,a3b8ad22-998e-40a9-acd1-d39dbdffc107,6c1bb38d42530e981f5b0d8597f07f3b,254408,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
b1e26350-1636-4dc0-8180-e7ad086fa45c.htseq.counts,TCGA-X2-A95T,2DE5878A-85D4-4A26-9E7D-8D0834CB72EC,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,120,United States,100,0,1543,YES,YES,YES,[Not Available],No,No,Consented,1548,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,8216cca0-a8e6-4c02-ae49-4808a563c077,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X2-A95T,TCGA-X2-A95T-01A,Primary Tumor,8216cca0-a8e6-4c02-ae49-4808a563c077,57812196c33b6c55db2eb245d2184cf5,253790,released,10,11,11,32,Leiomyosarcoma-Uterus,uLMS,HRD-low
b35d5dcb-b791-44e9-b5bd-0f47bca4cb75.htseq.counts,TCGA-DX-A7EF,254A48AE-81EE-4334-805C-3AA2A90D1C47,Undifferentiated Pleomorphic Sarcoma (UPS),15,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,570,YES,YES,YES,[Not Available],No,No,Consented,9,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,52bcd5c9-51df-4080-8c96-98d24cd166f4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7EF,TCGA-DX-A7EF-01A,Primary Tumor,52bcd5c9-51df-4080-8c96-98d24cd166f4,71b497b9845b7ce61f72a112fad0842d,249118,released,12,29,19,60,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
b4199d59-3f9e-4641-88df-66ddd3aed48c.htseq.counts,TCGA-DX-A6Z2,1BF5EA0F-6279-4278-A7D6-4B17D479283A,Leiomyosarcoma (LMS),67,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,2329,YES,YES,YES,[Not Available],No,No,Consented,62,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,b2392f30-ec88-49cf-a84f-6da646b1210d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6Z2,TCGA-DX-A6Z2-01A,Primary Tumor,b2392f30-ec88-49cf-a84f-6da646b1210d,6bbc8db2deaef0de10fadb08c5ad637a,254236,released,11,7,3,21,Leiomyosarcoma,LMS,HRD-low
b8868465-5204-43dc-9142-cad5b52f55a4.htseq.counts,TCGA-DX-A6YZ,42E7B86B-5089-4042-B0DF-EBC37290DCF1,Myxofibrosarcoma,19,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,2016,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,7d92d43a-5b17-446c-88b2-a40d2a918b6f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YZ,TCGA-DX-A6YZ-01A,Primary Tumor,7d92d43a-5b17-446c-88b2-a40d2a918b6f,5ab0e69e25c2eb0feb5d46d8597c5262,249354,released,11,27,15,53,Myxofibrosarcoma,MFS,HRD-high
b937c1f9-2443-4563-bc84-9c4a036249bc.htseq.counts,TCGA-3B-A9I0,34835D28-928D-4853-A55D-76A574277355,Leiomyosarcoma (LMS),88,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,104,United States,100,0,138,YES,YES,YES,[Not Available],No,No,Consented,74,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,78a23554-1278-493f-97d5-c879991859c7,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9I0,TCGA-3B-A9I0-01A,Primary Tumor,78a23554-1278-493f-97d5-c879991859c7,e311c2cd4110fa2b3947f65609c1367e,251485,released,6,7,4,17,Leiomyosarcoma,LMS,HRD-low
b9ff6e39-7906-4fc0-9365-1c012d9fff4a.htseq.counts,TCGA-DX-A6B9,A75F6D0F-1977-4D64-9E79-C100B471B272,Leiomyosarcoma (LMS),11,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,368,YES,YES,YES,[Not Available],No,No,Consented,6,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,a523064f-a7a1-458a-ab4f-98d825cb2f7f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6B9,TCGA-DX-A6B9-01A,Primary Tumor,a523064f-a7a1-458a-ab4f-98d825cb2f7f,43511855af3a774fa12a0fc449af9bb8,251154,released,5,4,4,13,Leiomyosarcoma,LMS,HRD-low
babb9304-0c2d-4ab1-b93b-efb77ad7fe5f.htseq.counts,TCGA-DX-A48O,E84CC153-84E6-4A2F-93BD-082169B4FD5C,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,10,632,YES,YES,YES,[Not Available],No,No,Consented,-26,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,efe27190-7831-4dbc-9036-26fe089bb71c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48O,TCGA-DX-A48O-01A,Primary Tumor,efe27190-7831-4dbc-9036-26fe089bb71c,c5ab5adf213cc5a56e597bdd5ca5dcd3,251947,released,12,10,7,29,Leiomyosarcoma,LMS,HRD-low
bad9e56b-33e3-4637-8c99-3f7be4359ed6.htseq.counts,TCGA-MB-A5YA,E17A6932-A117-4877-AA31-6B813D953823,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,270,United States,90,0,5,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,25f75de9-48d7-4c5d-86f7-a4decbe0da92,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MB-A5YA,TCGA-MB-A5YA-01A,Primary Tumor,25f75de9-48d7-4c5d-86f7-a4decbe0da92,52bae016140b68d0b58e0a50ab73b4d2,248510,released,2,8,3,13,Leiomyosarcoma,LMS,HRD-low
bae35a4f-f666-40a6-9048-4fc639712024.htseq.counts,TCGA-QQ-A5V2,CE02D680-4CF9-4ADE-974B-A17AF9301038,Undifferentiated Pleomorphic Sarcoma (UPS),41,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,280,United States,90,0,2318,YES,YES,NO,Pathology review of frozen section for TCGA determined histological subtype different from the pathology report,No,No,Consented,30,[Not Available],NO,[Not Available],[Not Available],[Not Available],[Not Available],NO,YES,a2250d4f-47f3-4ec8-96dc-d40cfccaefbc,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A5V2,TCGA-QQ-A5V2-01A,Primary Tumor,a2250d4f-47f3-4ec8-96dc-d40cfccaefbc,8048bd3a13b291fd6c175bc0dfc5a5e5,245783,released,0,0,0,0,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
bb41bd12-ad7c-4815-808e-e48cd7a15422.htseq.counts,TCGA-WK-A8XY,673F7169-6924-42A2-B705-1815D4445044,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,0,2432,YES,YES,YES,[Not Available],No,No,Consented,-2,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,4e54d46a-5401-4cd0-82f4-e174f099e9e5,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8XY,TCGA-WK-A8XY-01A,Primary Tumor,4e54d46a-5401-4cd0-82f4-e174f099e9e5,74cc0be4e29e6b0f2ff4e84da854b74f,252508,released,16,19,4,39,Leiomyosarcoma,LMS,HRD-low
bc079ef6-d481-4ee2-9365-b183444c4f75.htseq.counts,TCGA-IS-A3K8,F4D8A916-A0B5-4632-8E21-6A6D3EFB883B,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cassette,YES,200,United States,95,0,3506,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,-6,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,422bfae2-9b30-4c97-8419-2b2dfe5773ff,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IS-A3K8,TCGA-IS-A3K8-01A,Primary Tumor,422bfae2-9b30-4c97-8419-2b2dfe5773ff,42aa2921b613fa30dbd1c14dce8bd84e,249277,released,4,3,0,7,Leiomyosarcoma-Uterus,uLMS,HRD-low
bcdd49d6-2f39-4efd-9b52-0efb3e7713f0.htseq.counts,TCGA-DX-A6BF,2CE19E06-B543-48FE-9089-7C6B34512F7E,Dedifferentiated liposarcoma,22,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,204,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,65bb1aa9-42b5-4c17-878c-fb51e2a2a0de,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6BF,TCGA-DX-A6BF-01A,Primary Tumor,65bb1aa9-42b5-4c17-878c-fb51e2a2a0de,50a76b8f594e6d7e749a7fcca3efb4d4,242953,released,3,19,8,30,Dedifferentiated liposarcoma,ddLPS,HRD-low
bd2af24d-e63f-4757-b0f9-301acdec9f0f.htseq.counts,TCGA-DX-A23T,4C79E31C-C2DE-4E26-8361-A39952DE71A3,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,60,0,1591,YES,YES,YES,[Not Available],No,No,Consented,-18,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,51d234a0-24c3-46dc-83c3-6374a1e80571,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A23T,TCGA-DX-A23T-01A,Primary Tumor,51d234a0-24c3-46dc-83c3-6374a1e80571,fc176f9e0686fd29b9cad34cf26a1052,245694,released,0,2,4,6,Dedifferentiated liposarcoma,ddLPS,HRD-low
be630f1e-165e-45b7-b4f8-e80ac3ebe323.htseq.counts,TCGA-Z4-AAPF,9E87FC03-44AB-4561-B4D5-1E4592B58D66,Synovial Sarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,210,Russia,60,25,214,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,34298aec-ce8c-4554-85ca-e8304861b841,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-Z4-AAPF,TCGA-Z4-AAPF-01A,Primary Tumor,34298aec-ce8c-4554-85ca-e8304861b841,656ab309ec588348e74a6374fd04f3f1,252086,released,2,5,4,11,Synovial Sarcoma,SS,HRD-low
bf1ccb98-3f98-41b5-9612-cd335846947f.htseq.counts,TCGA-MB-A5Y9,870768F6-E62A-4A37-91DB-F0B7972D1570,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,730,United States,80,5,0,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,0,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,8567e205-e92c-4e1b-a582-eda2ef3d4856,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MB-A5Y9,TCGA-MB-A5Y9-01A,Primary Tumor,8567e205-e92c-4e1b-a582-eda2ef3d4856,b50a53a7b6830e25cc490e0be38ad656,243508,released,3,12,9,24,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
bffe7bae-47a4-43f0-b071-93ce7337d7fb.htseq.counts,TCGA-HS-A5N8,C91F6F45-EBFB-45CC-A0DD-9862B375336C,Leiomyosarcoma (LMS),-18,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,900,Canada,70,9,679,YES,YES,YES,[Not Available],No,No,Consented,-28,[Not Available],Digital Image,Uterus,[Not Available],[Not Available],[Not Available],NO,NO,9e977a45-ee45-49c8-8501-58848d4fc74a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-HS-A5N8,TCGA-HS-A5N8-01A,Primary Tumor,9e977a45-ee45-49c8-8501-58848d4fc74a,a8e4fd7b534d7fcef6124022bd54a0f9,253403,released,16,29,19,64,Leiomyosarcoma-Uterus,uLMS,HRD-high
c04668f9-44ff-473c-a054-2f691f58d051.htseq.counts,TCGA-QQ-A5VA,5C8A792E-362F-44AF-B94E-ED92F70715D6,Dedifferentiated liposarcoma,252,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,330,United States,90,0,5840,YES,YES,YES,[Not Available],No,No,Deceased,[Not Available],[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,3a846981-d1f7-45ce-9937-49850b2eb201,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A5VA,TCGA-QQ-A5VA-01A,Primary Tumor,3a846981-d1f7-45ce-9937-49850b2eb201,57043e8f80d9916c2f3a796420337a55,261509,released,29,22,13,64,Dedifferentiated liposarcoma,ddLPS,HRD-high
c0e7697c-4bb3-4e59-a71d-b59991eb8f5f.htseq.counts,TCGA-DX-A3LS,386455AA-441E-4BD2-A0A7-AD2ED278E5E6,Dedifferentiated liposarcoma,34,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,282,YES,YES,YES,[Not Available],No,No,Consented,23,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,1a4d2329-84d9-4737-90bc-52eb3f0ca7a6,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3LS,TCGA-DX-A3LS-01A,Primary Tumor,1a4d2329-84d9-4737-90bc-52eb3f0ca7a6,e24b3e03490044824dfd630c52fe5549,251124,released,7,11,2,20,Dedifferentiated liposarcoma,ddLPS,HRD-low
c168207a-b029-42c3-9cc2-b2ae8a264c86.htseq.counts,TCGA-VT-A80G,5A234A83-B7E4-4282-A8C2-F74DAF2C1D4D,Undifferentiated Pleomorphic Sarcoma (UPS),26,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,480,United States,98,3,143,YES,YES,YES,[Not Available],No,No,Consented,26,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,26f043ec-e906-46b2-98d0-7c2d0e91237a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-VT-A80G,TCGA-VT-A80G-01A,Primary Tumor,26f043ec-e906-46b2-98d0-7c2d0e91237a,5c24f72f891bebb4daaef3c82a72f62a,241366,released,10,27,15,52,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
c184dffc-92ac-44c0-a6bf-39beb0d8850b.htseq.counts,TCGA-DX-A23V,05ECD44B-5E88-47FD-9B4B-566AC6160ACF,Dedifferentiated liposarcoma,47,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,2722,YES,YES,YES,[Not Available],No,No,Consented,28,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,23df3d6e-6e76-4281-a363-32ec33c63c04,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A23V,TCGA-DX-A23V-01A,Primary Tumor,23df3d6e-6e76-4281-a363-32ec33c63c04,8a4a5cf3155371e187cecbbd75f57fae,249237,released,1,3,0,4,Dedifferentiated liposarcoma,ddLPS,HRD-low
c1b63308-8e44-46e6-9d83-10e4f69898ff.htseq.counts,TCGA-DX-A7EO,406DF608-27DB-4A3D-A692-A6EEFC2EB238,Synovial Sarcoma,68,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,4069,YES,YES,YES,[Not Available],No,No,Consented,55,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,0594f030-480d-42d8-920d-c088661ab2c6,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7EO,TCGA-DX-A7EO-01A,Primary Tumor,0594f030-480d-42d8-920d-c088661ab2c6,34df0a09270fe5893bca7fd253d9d401,248974,released,2,1,0,3,Synovial Sarcoma,SS,HRD-low
c29c9813-5e7e-4946-8f20-1a7a0c7f9911.htseq.counts,TCGA-DX-AB2F,2FC10297-1618-4EB0-9A66-630E40EA677F,Dedifferentiated liposarcoma,25,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,49,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,2380f6b7-ba7d-40b7-8dc0-fcceb47fbdb2,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2F,TCGA-DX-AB2F-01A,Primary Tumor,2380f6b7-ba7d-40b7-8dc0-fcceb47fbdb2,dab44a384db458c3ddef3620a999d7a4,250030,released,5,26,12,43,Dedifferentiated liposarcoma,ddLPS,HRD-high
c364d724-8fa5-4590-bbec-0894925ced44.htseq.counts,TCGA-KD-A5QS,7B8B0BE7-184D-4334-88F3-58BF561CE055,Leiomyosarcoma (LMS),-5,YES,"Other Method, specify",TAH/BSO,[Not Applicable],Cryovial,YES,100,United States,65,0.5,958,YES,YES,YES,[Not Available],No,No,Consented,-5,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],NO,YES,bf2f6ccc-2d8d-4ba4-8c16-ada936061b13,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-KD-A5QS,TCGA-KD-A5QS-01A,Primary Tumor,bf2f6ccc-2d8d-4ba4-8c16-ada936061b13,804814a288c7cd3234ec98330b92bc57,246418,released,17,33,30,80,Leiomyosarcoma-Uterus,uLMS,HRD-high
c3fa1b6a-fbb6-420c-96bf-4df1646bcdc9.htseq.counts,TCGA-FX-A3NK,BF1A4471-C33B-49A8-B9A6-C9AE183A5C94,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,30,United States,70,0,73,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,-4,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,YES,NO,0c68d1d2-aa48-4656-8660-f40cf1ba1699,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A3NK,TCGA-FX-A3NK-01A,Primary Tumor,0c68d1d2-aa48-4656-8660-f40cf1ba1699,ae03a8f08847ec2258d1cfe40445d208,251766,released,12,14,3,29,Dedifferentiated liposarcoma,ddLPS,HRD-low
c4ca9cd9-1e65-4bfd-86de-e83201b079fa.htseq.counts,TCGA-MJ-A68J,E2F9A40D-8C76-44D7-83B3-6423C1DE3463,Myxofibrosarcoma,72,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,93,United States,90,0,459,YES,YES,YES,[Not Available],No,No,Consented,72,[Not Available],Slide,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,a9c34a4c-2326-4571-bf03-64fb12b01e7f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MJ-A68J,TCGA-MJ-A68J-01A,Primary Tumor,a9c34a4c-2326-4571-bf03-64fb12b01e7f,9e1aaa145aaeacdea885f582b082815f,250101,released,0,0,1,1,Myxofibrosarcoma,MFS,HRD-low
c504f1c1-c643-4454-9acf-a00e24e38f44.htseq.counts,TCGA-K1-A42X,F64F2F08-7F2A-44A2-A1A6-90A77DC43D06,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,400,United States,90,0,3155,YES,YES,YES,[Not Available],No,No,Consented,2048,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,e2fe9869-a489-4b6c-878f-d2a07929e760,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A42X,TCGA-K1-A42X-02A,Recurrent Tumor,e2fe9869-a489-4b6c-878f-d2a07929e760,221585a5baa982ead002e238f775f9c0,250045,released,11,12,12,35,Leiomyosarcoma,LMS,HRD-low
c61bf74e-dbfe-4d2a-8164-b7d1388dfd0f.htseq.counts,TCGA-DX-A48U,15811E5D-9D25-4562-B902-CCB24A1A97CF,Leiomyosarcoma (LMS),27,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,2512,YES,YES,YES,[Not Available],No,No,Consented,14,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,b6ed61a4-0f7d-402d-809d-b56f9496814e,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48U,TCGA-DX-A48U-01A,Primary Tumor,b6ed61a4-0f7d-402d-809d-b56f9496814e,d1fda73886d9ab449959b8911b5d3152,250011,released,8,9,6,23,Leiomyosarcoma,LMS,HRD-low
cb26f33d-b1b7-411a-9f21-7e3ea98694d9.htseq.counts,TCGA-QQ-A8VG,E8BEEA6F-975D-43AA-9BB9-B65F260FF2EE,Malignant Peripheral Nerve Sheath Tumors (MPNST),82,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,270,United States,80,0,796,YES,YES,YES,[Not Available],No,No,Consented,41,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,849bb4e0-350d-4274-b4ad-822256362ff2,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A8VG,TCGA-QQ-A8VG-01A,Primary Tumor,849bb4e0-350d-4274-b4ad-822256362ff2,459c386ef0f9b58442b5844ba4ad9fae,252539,released,1,2,1,4,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-low
cb9beb00-4b21-454f-a865-726bd8120d46.htseq.counts,TCGA-DX-AB3C,D671FC02-8E4D-4A21-BADD-B5C478404287,Synovial Sarcoma,22,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1989,YES,YES,YES,[Not Available],No,No,Consented,13,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,9e909488-6d11-4410-a549-2471f9705c3d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB3C,TCGA-DX-AB3C-01A,Primary Tumor,9e909488-6d11-4410-a549-2471f9705c3d,81f81c45646c6eeeb17fccdbe9fc7886,248337,released,3,0,2,5,Synovial Sarcoma,SS,HRD-low
cc6a2e77-2220-4046-b653-e8b4f9dd39c7.htseq.counts,TCGA-DX-A6YV,6245D97D-1AF8-4C78-8BBF-840EE4E7BD44,Myxofibrosarcoma,29,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,1680,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,fe71a5e0-9c07-4d5c-8724-a16cdc852abd,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YV,TCGA-DX-A6YV-01A,Primary Tumor,fe71a5e0-9c07-4d5c-8724-a16cdc852abd,33f8fa2bc990aef17deb974b745d7a5e,251350,released,10,17,11,38,Myxofibrosarcoma,MFS,HRD-low
d01c31fc-2f14-4530-994c-495daf65b11d.htseq.counts,TCGA-X6-A8C5,E2A08E48-2EBE-4DE3-85AC-47DC7A412A9E,Leiomyosarcoma (LMS),0,YES,Excisional Biopsy,[Not Applicable],[Not Applicable],Cryomold,YES,1400,United States,90,5,800,YES,YES,YES,[Not Available],No,No,Consented,49,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,0135d5dd-4363-4594-b8bb-16cd7f38e8a6,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A8C5,TCGA-X6-A8C5-01A,Primary Tumor,0135d5dd-4363-4594-b8bb-16cd7f38e8a6,7077fa2aef1f48cdd823bdfac4ed54ba,252341,released,7,11,7,25,Leiomyosarcoma,LMS,HRD-low
d09b6dac-06e7-473f-bf5a-8998cdf6e74e.htseq.counts,TCGA-DX-A8BT,5A9EBCFD-6F27-4C33-9DA5-661AC5E7814E,Undifferentiated Pleomorphic Sarcoma (UPS),24,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,806,YES,YES,YES,[Not Available],No,No,Consented,18,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,7202e142-3ee3-40b2-8b50-2bef43b92dae,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BT,TCGA-DX-A8BT-01A,Primary Tumor,7202e142-3ee3-40b2-8b50-2bef43b92dae,5297bd6e37c47f0e6313c850b6b98f26,251161,released,3,20,8,31,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
d184d4f3-dc4e-4643-86b8-20dfaf6ee653.htseq.counts,TCGA-QQ-A8VF,D7FE16E1-E892-4A4C-A491-1A6CDED8467A,Leiomyosarcoma (LMS),31,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,220,United States,90,5,2582,YES,YES,YES,[Not Available],No,No,Consented,31,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,1f59075a-6333-41f9-92ec-947937c47353,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A8VF,TCGA-QQ-A8VF-01A,Primary Tumor,1f59075a-6333-41f9-92ec-947937c47353,a47b8495ce1918651f2d0ef87868b332,251953,released,9,12,4,25,Leiomyosarcoma,LMS,HRD-low
d2f12c0b-426c-40ad-b56b-ed79251d2d94.htseq.counts,TCGA-DX-A6B7,1C323559-F2D0-480B-9DAB-9AC014FA9C41,Leiomyosarcoma (LMS),20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,322,YES,YES,YES,[Not Available],No,No,Consented,16,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,f2d4c380-42d4-443f-b3d4-9c00f8536f0d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6B7,TCGA-DX-A6B7-01A,Primary Tumor,f2d4c380-42d4-443f-b3d4-9c00f8536f0d,abd788426eb399ae47fb4bafd9ffe4d3,250115,released,5,31,5,41,Leiomyosarcoma,LMS,HRD-low
d30e88b3-7ebc-4c95-afce-fb8e07988f3a.htseq.counts,TCGA-DX-A23Y,64235D51-B1B8-46AB-87EF-A7CAEB394A6D,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,0,1672,YES,YES,YES,[Not Available],No,No,Consented,-6,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,eae41b77-8a83-4402-8436-48a93fd30f5f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A23Y,TCGA-DX-A23Y-01A,Primary Tumor,eae41b77-8a83-4402-8436-48a93fd30f5f,d71aada696f9d68459c6aa82672e7478,249765,released,7,25,12,44,Dedifferentiated liposarcoma,ddLPS,HRD-high
d4365d0e-30d2-49cd-880e-a6d773601204.htseq.counts,TCGA-DX-A7EL,E9C18A21-A583-4031-80D6-4ABC8C67FC28,Leiomyosarcoma (LMS),13,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,100,0,2403,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,9,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,c9ca2cbb-86b5-45ba-b45e-1226e2338a38,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A7EL,TCGA-DX-A7EL-01A,Primary Tumor,c9ca2cbb-86b5-45ba-b45e-1226e2338a38,a1abb56539805a244829342cfab44607,253535,released,6,7,17,30,Leiomyosarcoma,LMS,HRD-low
d5103c4b-9d85-46c4-86ca-e555e1eaaf7e.htseq.counts,TCGA-3B-A9HX,C0327A7B-4AFA-47B5-91B8-93162B16E144,Leiomyosarcoma (LMS),17,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,100,United States,100,5,56,YES,YES,YES,[Not Available],No,No,Consented,-13,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,c446c0c7-7cc9-4229-bdaf-dcf56d50f3e4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HX,TCGA-3B-A9HX-01A,Primary Tumor,c446c0c7-7cc9-4229-bdaf-dcf56d50f3e4,82065723f9c68a16449d9b6ac07363c9,253662,released,12,18,9,39,Leiomyosarcoma,LMS,HRD-low
d5c8e330-8889-475f-b29e-4e934b39fe56.htseq.counts,TCGA-3B-A9HQ,C9F8D00B-B831-4CE9-9133-9551F03C133F,Leiomyosarcoma (LMS),36,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,100,United States,96,5,182,YES,YES,YES,[Not Available],No,No,Consented,35,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,267c0844-eeac-482c-9ebb-042237516b24,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HQ,TCGA-3B-A9HQ-01A,Primary Tumor,267c0844-eeac-482c-9ebb-042237516b24,7a838111cf4c7340af6d24c73eea94ce,252270,released,6,10,7,23,Leiomyosarcoma,LMS,HRD-low
d6b51a36-7ce9-4044-809b-e48e9213abd8.htseq.counts,TCGA-FX-A8OO,7339055D-A674-401D-BE06-4C4BBCA1FD95,Synovial Sarcoma,60,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,63,United States,90,0,87,YES,YES,YES,[Not Available],No,No,Consented,63,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],YES,NO,b3ac5070-9a6b-4d72-aed7-3248f763ec10,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A8OO,TCGA-FX-A8OO-01A,Primary Tumor,b3ac5070-9a6b-4d72-aed7-3248f763ec10,07e80344b67b3cb9ca3dc8cd9a8bd817,253638,released,0,1,0,1,Synovial Sarcoma,SS,HRD-low
d70b05b6-aef5-43f6-b8f6-d670c5672478.htseq.counts,TCGA-DX-A6Z0,19C821D5-C05C-42AD-AACA-749565EFF239,Myxofibrosarcoma,120,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,2593,YES,YES,YES,[Not Available],No,No,Consented,102,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,e8c5661e-dab6-4141-9421-533e4405383c,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6Z0,TCGA-DX-A6Z0-01A,Primary Tumor,e8c5661e-dab6-4141-9421-533e4405383c,fb1faac12b9f873a99988e974fdaeb5f,252814,released,20,23,15,58,Myxofibrosarcoma,MFS,HRD-high
d79ebd1c-13fb-419f-8f75-27d963b8bd48.htseq.counts,TCGA-DX-A6BG,F6D48B22-8D82-47B0-8D1E-675E235DCA98,Dedifferentiated liposarcoma,0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,85,5,157,YES,YES,YES,[Not Available],No,No,Consented,-5,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,80edc99b-0f27-462b-907b-3dd56d4d165a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6BG,TCGA-DX-A6BG-01A,Primary Tumor,80edc99b-0f27-462b-907b-3dd56d4d165a,ff58e25811d7764cb325a9a36d020673,248899,released,0,0,0,0,Dedifferentiated liposarcoma,ddLPS,HRD-low
d7ba48f3-701f-4adf-9be4-41ebff6b8aa3.htseq.counts,TCGA-MO-A47R,3D38F7C9-00DD-47C1-8649-C50574953AAB,Leiomyosarcoma (LMS),3,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,450,Vietnam,80,0,39,YES,YES,YES,[Not Available],No,No,Consented,3,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,bc65fd39-7da5-418c-8e79-db4ade104ede,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MO-A47R,TCGA-MO-A47R-01A,Primary Tumor,bc65fd39-7da5-418c-8e79-db4ade104ede,3c5c53622efcd2dbeeab2bf1e2dd1d23,247435,released,1,5,12,18,Leiomyosarcoma,LMS,HRD-low
d946a385-bf7e-4e8c-a371-fa4756762054.htseq.counts,TCGA-DX-A1KX,A4A04CCE-6A96-44B2-BF26-BA558AFEF381,Dedifferentiated liposarcoma,19,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,520,YES,YES,YES,[Not Available],No,No,Consented,15,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,abb538a8-9db4-44f7-aeac-506941106c29,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1KX,TCGA-DX-A1KX-01A,Primary Tumor,abb538a8-9db4-44f7-aeac-506941106c29,70fb010b3de1c4fbd6c0c22f16919480,248623,released,6,34,16,56,Dedifferentiated liposarcoma,ddLPS,HRD-high
dbce907f-bdea-4b0e-8938-ad2897b937bf.htseq.counts,TCGA-DX-A8BL,B6852026-F3FF-4830-B9D6-A998ADCE6FDD,Undifferentiated Pleomorphic Sarcoma (UPS),12,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,99,0,972,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,ec8119a4-0594-4f25-b3a3-86fae30794bc,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BL,TCGA-DX-A8BL-01A,Primary Tumor,ec8119a4-0594-4f25-b3a3-86fae30794bc,a2f34b54e7267bb043a1e113857d93cb,247941,released,12,26,21,59,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
defcfc43-30e2-4c27-bca3-589cad477df6.htseq.counts,TCGA-X9-A973,906F883B-EF84-415F-87F6-E248A6ECB9CF,Undifferentiated Pleomorphic Sarcoma (UPS),15,YES,Surgical Resection,[Not Applicable],wrapped in foil; then stored in storage bag,Other,YES,280,United States,95,5,758,YES,YES,YES,[Not Available],No,No,Consented,735,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,8860a4dd-b0fb-4afb-b86d-188eb68ffdc4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X9-A973,TCGA-X9-A973-01A,Primary Tumor,8860a4dd-b0fb-4afb-b86d-188eb68ffdc4,be8dfc638b3b4fd2241d8af3a631df85,251530,released,0,16,3,19,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
df23e234-4acd-4eb5-b271-ff6bb18ccc1a.htseq.counts,TCGA-DX-A1L1,023378D5-5729-407A-9633-9F4DEE67C869,Dedifferentiated liposarcoma,31,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,1064,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,42ac4a0f-852a-46d8-981a-441ad000bb14,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1L1,TCGA-DX-A1L1-01A,Primary Tumor,42ac4a0f-852a-46d8-981a-441ad000bb14,e4362b3410fdbef9edb1ca82a423ae0f,251525,released,13,29,16,58,Dedifferentiated liposarcoma,ddLPS,HRD-high
df48010e-3c93-4a9b-8655-34023018fd19.htseq.counts,TCGA-DX-A3UD,BF4FC4A5-AE1E-4363-A440-A841464AE81A,Leiomyosarcoma (LMS),20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,75,0,693,YES,YES,YES,[Not Available],No,No,Consented,15,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,6f12b65b-d282-4b6b-952c-9316b8d350d9,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3UD,TCGA-DX-A3UD-01A,Primary Tumor,6f12b65b-d282-4b6b-952c-9316b8d350d9,f6f977da8cb85d51101fa6a7febb5c7a,252561,released,4,14,11,29,Leiomyosarcoma,LMS,HRD-low
df76b221-d666-40c1-8b02-3ed818c0a831.htseq.counts,TCGA-DX-AB3A,F1E4A88F-57B5-4E29-BFB2-D6FC8FDBE209,Dedifferentiated liposarcoma,20,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,1701,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,8,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,90ce4585-a0bb-4a36-951f-a2bf9a573b4a,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB3A,TCGA-DX-AB3A-01A,Primary Tumor,90ce4585-a0bb-4a36-951f-a2bf9a573b4a,2ff077f4d7998170a90de63420bafdd2,249390,released,6,14,3,23,Dedifferentiated liposarcoma,ddLPS,HRD-low
e04f45cb-e226-47b6-8e15-5bfcdec1a078.htseq.counts,TCGA-FX-A3RE,8FAEDD92-D7FA-452A-8210-741118E516F7,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,173,United States,90,0,100,YES,YES,YES,[Not Available],No,No,Consented,2,[Not Available],NO,[Not Available],[Not Available],[Not Available],NO,YES,NO,623b4f23-75b1-49d1-bcf9-98d47bff5727,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A3RE,TCGA-FX-A3RE-01A,Primary Tumor,623b4f23-75b1-49d1-bcf9-98d47bff5727,4e85f1f7fbe883a4d187510b74c074f6,249865,released,6,18,20,44,Leiomyosarcoma,LMS,HRD-high
e18f1492-00e7-4f95-85da-9cf0bd4ca229.htseq.counts,TCGA-IW-A3M4,F854DB6B-57CB-4DA7-9252-B2ADE22C2675,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,150,United States,100,0,2198,YES,YES,YES,[Not Available],No,No,Consented,0,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,c62a9a17-da02-4232-ad93-47d3c6f27601,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IW-A3M4,TCGA-IW-A3M4-01A,Primary Tumor,c62a9a17-da02-4232-ad93-47d3c6f27601,4de13ed1d1d86918669b0d92604a5149,250713,released,8,4,5,17,Leiomyosarcoma-Uterus,uLMS,HRD-low
e3402ce9-c06b-48e2-b5f4-ba81d3e1dac7.htseq.counts,TCGA-FX-A76Y,7CC6EB42-FAC5-48C6-A2EE-5BC49D0B3F8F,Leiomyosarcoma (LMS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,58,United States,90,0,89,YES,YES,YES,[Not Available],No,No,Consented,2,[Not Available],NO,Uterus,[Not Available],[Not Available],[Not Available],YES,NO,efff5fa4-2d0c-4660-8530-d46ffa45ad60,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-FX-A76Y,TCGA-FX-A76Y-01A,Primary Tumor,efff5fa4-2d0c-4660-8530-d46ffa45ad60,e9ac22955791065cf208ca0fac8d700d,254170,released,4,4,5,13,Leiomyosarcoma-Uterus,uLMS,HRD-low
e42325eb-57ce-4b5b-af02-ec1b0fe0644d.htseq.counts,TCGA-X6-A8C2,40BBDDF9-5D42-4D41-991B-60EA008E5E37,Undifferentiated Pleomorphic Sarcoma (UPS),22,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,250,United States,95,0,222,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,f358eeb0-6fde-4dd8-8981-ab7ae3919d95,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A8C2,TCGA-X6-A8C2-01A,Primary Tumor,f358eeb0-6fde-4dd8-8981-ab7ae3919d95,bcec35e8874c3640eb0d855211c78ae0,249717,released,11,28,20,59,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
e494625c-14cb-4544-a85f-708ecd30a592.htseq.counts,TCGA-QC-A6FX,14CC693C-A747-470A-88B5-FFF9EB3C250D,Undifferentiated Pleomorphic Sarcoma (UPS),37,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,150,United States,50,50,62,NO,NO,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,28,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,a87038c9-9c42-43e1-a01e-2c88b9181f76,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QC-A6FX,TCGA-QC-A6FX-01A,Primary Tumor,a87038c9-9c42-43e1-a01e-2c88b9181f76,153ce79a5e79f4a58ea8c4d2cb5849ef,249027,released,19,29,14,62,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
e5a92a4a-8d25-4c7d-be08-6ea7b13008ce.htseq.counts,TCGA-3B-A9HS,943D3DB6-7F56-4BE1-8F67-33C2C1C02F0A,Leiomyosarcoma (LMS),47,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,110,United States,90,0,78,YES,YES,YES,[Not Available],No,No,Consented,6,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,8ce62278-97e2-4d85-be98-b04798331110,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HS,TCGA-3B-A9HS-01A,Primary Tumor,8ce62278-97e2-4d85-be98-b04798331110,276e5658d9a27328ff3b623104e895e2,253209,released,7,18,21,46,Leiomyosarcoma,LMS,HRD-high
e825aae8-1601-42a9-9c28-cdedd2b932df.htseq.counts,TCGA-DX-A48L,BB4FA564-3128-44CB-A852-2BF4D26CB981,Leiomyosarcoma (LMS),55,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,10,911,YES,YES,YES,[Not Available],No,No,Consented,55,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,54c167c1-2a46-4120-abef-557fb9579ef8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48L,TCGA-DX-A48L-01A,Primary Tumor,54c167c1-2a46-4120-abef-557fb9579ef8,994d14277462df1a201149d427718a6a,251813,released,5,14,11,30,Leiomyosarcoma,LMS,HRD-low
e9d959e9-5e2d-4652-9ba4-4aeb1e7459be.htseq.counts,TCGA-VT-AB3D,5666B6B0-84B1-4A95-A8A6-43D61D0930E1,Undifferentiated Pleomorphic Sarcoma (UPS),-7,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,130,United States,100,0,113,YES,YES,YES,[Not Available],No,No,Consented,-12,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,d3247c4c-37a9-4c5f-b536-335c6cd931c8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-VT-AB3D,TCGA-VT-AB3D-01A,Primary Tumor,d3247c4c-37a9-4c5f-b536-335c6cd931c8,15378bfeb18e67504d39664efd1e8e7c,248830,released,20,23,12,55,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
e9f33a57-8008-4f92-aaad-8fe10da445dd.htseq.counts,TCGA-DX-A6YR,A9B4F32F-030E-4523-85D6-372DD1A058CB,Myxofibrosarcoma,34,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,659,YES,YES,YES,[Not Available],No,No,Consented,22,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,826a59c5-26e9-4526-83f4-aa746944892d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A6YR,TCGA-DX-A6YR-01A,Primary Tumor,826a59c5-26e9-4526-83f4-aa746944892d,7bf4a3c7dc65c890c1ba514ec7bcdfeb,249229,released,13,29,12,54,Myxofibrosarcoma,MFS,HRD-high
ec2545d1-5312-4659-9feb-17a72b7392f3.htseq.counts,TCGA-DX-AB2H,D2332896-4F5C-4AE0-AC72-B7CBB49A835C,Dedifferentiated liposarcoma,32,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,70,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,21,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,95ff6b36-5ce2-4910-867d-5b9b81df32a1,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2H,TCGA-DX-AB2H-01A,Primary Tumor,95ff6b36-5ce2-4910-867d-5b9b81df32a1,9c396e5a59fa98ccf02d732e338927c9,250234,released,6,6,10,22,Dedifferentiated liposarcoma,ddLPS,HRD-low
ec383191-39b9-4168-aa60-44d9bc181f80.htseq.counts,TCGA-DX-A1KY,96EF5730-651A-4A02-A879-FB5C6BBFFF4B,Dedifferentiated liposarcoma,46,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,505,YES,YES,YES,[Not Available],No,No,Consented,28,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,d19ee7be-9410-4b78-b95d-9fe6c9c80530,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A1KY,TCGA-DX-A1KY-01A,Primary Tumor,d19ee7be-9410-4b78-b95d-9fe6c9c80530,b735cc0457460c631d9c598767e3740e,252993,released,14,24,12,50,Dedifferentiated liposarcoma,ddLPS,HRD-high
ecdb44a4-9a1c-4cf6-94b2-5b437eef2361.htseq.counts,TCGA-IE-A4EK,9963DA13-6EA7-48A3-A3DE-1C6A38F977B9,Leiomyosarcoma (LMS),40,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,170,United States,85,15,68,YES,YES,YES,[Not Available],No,No,Consented,40,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,NO,ee8e5ff0-691b-4a54-a850-ba907b1c14c4,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IE-A4EK,TCGA-IE-A4EK-01A,Primary Tumor,ee8e5ff0-691b-4a54-a850-ba907b1c14c4,daf91293fe3f523aa714b54e086fc097,246040,released,5,4,5,14,Leiomyosarcoma,LMS,HRD-low
ecfbf72d-ecf1-4f45-992a-14a1776cc18d.htseq.counts,TCGA-DX-AB2T,80C1A2AC-AFFF-46C8-B4A6-8F2F46F32211,Myxofibrosarcoma,74,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,2023,YES,YES,YES,[Not Available],No,No,Consented,70,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,78753779-2183-41f5-9ca9-ef531d533d93,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2T,TCGA-DX-AB2T-01A,Primary Tumor,78753779-2183-41f5-9ca9-ef531d533d93,c0c3d0d93f715290a6484e8cbac4fccf,251136,released,12,21,24,57,Myxofibrosarcoma,MFS,HRD-high
ef02d82e-c9d0-4f22-82c6-ba7db7b00d0f.htseq.counts,TCGA-UE-A6QT,3D2C731C-4D50-479B-BAE0-504F533DFDF3,Undifferentiated Pleomorphic Sarcoma (UPS),7,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cassette,YES,1358,Vietnam,100,0,91,YES,YES,NO,Pathology analysis at TSS determined a specific histological subtype different from original pathology report,No,No,Consented,2,[Not Available],Slide,Head/Neck,[Not Available],[Not Available],[Not Available],NO,YES,b3e89f05-07a2-41df-9705-37b8c3c2dbe0,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-UE-A6QT,TCGA-UE-A6QT-01A,Primary Tumor,b3e89f05-07a2-41df-9705-37b8c3c2dbe0,ca99f53cfe0b2d62e253e7b4258eac99,247015,released,4,5,1,10,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
ef8842e5-d2b7-438c-9fc0-f48b736cd2b1.htseq.counts,TCGA-K1-A3PO,23B9DCA0-A8A2-4798-8953-9F5A03EF7B2B,Leiomyosarcoma (LMS),11,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,460,United States,60,2,551,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,70912730-615c-4d98-9d0e-94bfd3a78c81,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-K1-A3PO,TCGA-K1-A3PO-01A,Primary Tumor,70912730-615c-4d98-9d0e-94bfd3a78c81,c22775fc03c4dc6b41c46f2ef091a0f6,251475,released,2,2,0,4,Leiomyosarcoma,LMS,HRD-low
efa6a46c-308e-45cb-9e74-f86842ecf48b.htseq.counts,TCGA-PC-A5DK,153BF526-77DF-46A0-B890-57E2D57A50F4,Leiomyosarcoma (LMS),18,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,200,United States,100,0,3224,YES,YES,YES,[Not Available],No,No,Consented,9,[Not Available],Slide,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,90993bfc-dbfe-43ed-aa61-47eafdd3384f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-PC-A5DK,TCGA-PC-A5DK-01A,Primary Tumor,90993bfc-dbfe-43ed-aa61-47eafdd3384f,20f24f5bddb8526b49e02304f4dc6f6b,249133,released,4,4,3,11,Leiomyosarcoma,LMS,HRD-low
eff0bfff-4b66-4fd1-9f5b-ceb3cf6c7c81.htseq.counts,TCGA-IS-A3KA,F8495459-CAF7-47CA-9B6A-7FE11FF1BA11,Leiomyosarcoma (LMS),31,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cassette,YES,200,United States,90,0,2707,YES,YES,YES,[Not Available],No,No,Consented,20,[Not Available],NO,Uterus,[Not Available],[Not Available],NO,NO,YES,78a5c302-4d3c-44b7-800e-a6a39f0997af,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-IS-A3KA,TCGA-IS-A3KA-01A,Primary Tumor,78a5c302-4d3c-44b7-800e-a6a39f0997af,117a0b148f268d70465f75b2c9bb1abb,249480,released,8,24,16,48,Leiomyosarcoma-Uterus,uLMS,HRD-high
f0486819-c1dd-4ae0-b191-77570ff2abb0.htseq.counts,TCGA-DX-AB2V,884945C4-393F-46D2-B23E-EDEB096F8B71,Myxofibrosarcoma,26,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,2779,YES,YES,YES,[Not Available],No,No,Consented,7,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,72531a3a-3565-4ea9-8d70-6ca2af13d953,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2V,TCGA-DX-AB2V-01A,Primary Tumor,72531a3a-3565-4ea9-8d70-6ca2af13d953,81aa094ebc97858495633a17de6772cd,249867,released,13,33,21,67,Myxofibrosarcoma,MFS,HRD-high
f10cc48c-4566-41fd-8dbf-66393ee09d70.htseq.counts,TCGA-QQ-A8VH,CCBA79C4-8873-478A-AD99-0DB99C034A91,Malignant Peripheral Nerve Sheath Tumors (MPNST),76,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,210,United States,80,0,940,YES,YES,YES,[Not Available],No,No,Deceased,[Not Available],[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,42a4a980-9b8a-420d-a3c3-f99d389a3739,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A8VH,TCGA-QQ-A8VH-01A,Primary Tumor,42a4a980-9b8a-420d-a3c3-f99d389a3739,e0a254a98ce4fb5535f1d7b59d302f63,252810,released,22,24,9,55,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-high
f2ef820d-7818-40b0-8e44-703e22ea4e14.htseq.counts,TCGA-DX-A2IZ,B68F7194-1F05-4009-8ED2-58C5EBBCABA8,Dedifferentiated liposarcoma,15,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,60,0,1626,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],NO,YES,edffe7f3-8e34-4a76-8d84-ca0e9f6df0a8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A2IZ,TCGA-DX-A2IZ-01A,Primary Tumor,edffe7f3-8e34-4a76-8d84-ca0e9f6df0a8,6808e6eaa3ce01c34488d668793e448d,256256,released,1,5,4,10,Dedifferentiated liposarcoma,ddLPS,HRD-low
f4244104-92cc-4265-bd19-25437741ca5b.htseq.counts,TCGA-DX-AB2W,D0246682-F768-4B77-B475-68D9094A705D,Undifferentiated Pleomorphic Sarcoma (UPS),32,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,0,2841,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,27,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,5bc6b75e-20d0-4744-99d9-49b777fdc0e1,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2W,TCGA-DX-AB2W-01A,Primary Tumor,5bc6b75e-20d0-4744-99d9-49b777fdc0e1,d0630e17605be49b9c2672c04828ad66,244024,released,25,28,29,82,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
f4709aa5-d0ad-48bc-9390-642584a3d837.htseq.counts,TCGA-DX-A48K,1D7C6C1D-8B93-48C4-9E7F-496331430A47,Leiomyosarcoma (LMS),28,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,80,0,405,YES,YES,YES,[Not Available],No,No,Consented,6,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,686f627a-1d88-48b5-8af6-2806393d96bf,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A48K,TCGA-DX-A48K-01A,Primary Tumor,686f627a-1d88-48b5-8af6-2806393d96bf,f545f0b0e652da600be7956eab770eba,248293,released,11,17,7,35,Leiomyosarcoma,LMS,HRD-low
f4e1db6d-9b03-4955-a759-822283c93c46.htseq.counts,TCGA-SI-AA8B,4421DE00-0D62-42D7-A8CA-1C8AB38D1C57,Undifferentiated Pleomorphic Sarcoma (UPS),69,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,960,United States,100,20,90,YES,YES,YES,[Not Available],No,No,Consented,70,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,ac4948dc-3867-40b4-8d9c-805452123520,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SI-AA8B,TCGA-SI-AA8B-01A,Primary Tumor,ac4948dc-3867-40b4-8d9c-805452123520,1112b051462574c4c590735f61520594,247443,released,11,22,17,50,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
f5f92079-466f-4e7b-86ab-ccef253e963a.htseq.counts,TCGA-X6-A8C3,8EACD13B-B2D6-4002-A22D-26FE426E47AB,Myxofibrosarcoma,35,YES,Excisional Biopsy,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,86,YES,YES,YES,[Not Available],No,No,Consented,24,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,14a7dc8b-16c9-4ae6-83d0-c89d46c7dc93,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-X6-A8C3,TCGA-X6-A8C3-01A,Primary Tumor,14a7dc8b-16c9-4ae6-83d0-c89d46c7dc93,da1f8655cbe4f082084722462477a9fe,250849,released,12,31,18,61,Myxofibrosarcoma,MFS,HRD-high
f65571bf-793a-43d5-93aa-c85bac4dca56.htseq.counts,TCGA-SI-A71O,9947F0B3-1A35-4370-AD31-633B0740B0BF,Malignant Peripheral Nerve Sheath Tumors (MPNST),0,YES,Excisional Biopsy,[Not Applicable],Biospecimen Storage Bag,Other,YES,550,United States,95,40,165,YES,YES,YES,[Not Available],No,No,Consented,62,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,3d86761e-d97f-4137-90b3-8965758c497f,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SI-A71O,TCGA-SI-A71O-01A,Primary Tumor,3d86761e-d97f-4137-90b3-8965758c497f,f64950ff05a40dd74f0798e977f136de,252547,released,24,21,24,69,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-high
f701554c-c851-4bfb-8bd1-18f0b268ac68.htseq.counts,TCGA-DX-A3U8,D40B2922-FA6A-4AFA-BDBF-7B517384AF74,Leiomyosarcoma (LMS),99,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,492,YES,YES,YES,[Not Available],No,No,Consented,95,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],NO,NO,YES,1720402f-9b82-44bb-8a48-9a1c0dc3b169,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A3U8,TCGA-DX-A3U8-01A,Primary Tumor,1720402f-9b82-44bb-8a48-9a1c0dc3b169,c39f93450cc67553f08d38899a5447bf,250060,released,2,4,1,7,Leiomyosarcoma,LMS,HRD-low
f7377bab-330a-4f85-a2e7-ddd46659bec2.htseq.counts,TCGA-DX-AB2P,567FFCAA-E226-438A-8FB7-184DD6F563AE,Undifferentiated Pleomorphic Sarcoma (UPS),48,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,95,0,2899,YES,YES,YES,[Not Available],"Yes, History of Prior Malignancy",No,Consented,29,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,25055bf4-23ef-498e-ad3b-ec5641d7652d,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-AB2P,TCGA-DX-AB2P-01A,Primary Tumor,25055bf4-23ef-498e-ad3b-ec5641d7652d,36edc71a4c28b49c78bd121d56e327d7,249606,released,8,30,24,62,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
fa8b56b5-f4df-4751-8bc4-6d89e6c391bb.htseq.counts,TCGA-MB-A5Y8,3DD4532A-8CFE-4900-8D7E-AF4303645705,Undifferentiated Pleomorphic Sarcoma (UPS),18,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,380,United States,90,5,18,YES,YES,YES,[Not Available],No,No,Consented,18,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,9e83bc2b-be87-48fb-9a06-d14b912c3cfd,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-MB-A5Y8,TCGA-MB-A5Y8-01A,Primary Tumor,9e83bc2b-be87-48fb-9a06-d14b912c3cfd,5ccc23fb2f71268ae41f0d55baa4a624,247802,released,14,12,12,38,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-low
fb783ec9-4ca1-4354-bb51-29b5bbb909b3.htseq.counts,TCGA-3B-A9HZ,AE587287-A6C6-47B4-AB4D-EC4B9BC59FB9,Leiomyosarcoma (LMS),76,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,112,United States,100,0,144,YES,YES,YES,[Not Available],No,No,Consented,49,[Not Available],NO,Chest,[Not Available],[Not Available],[Not Available],NO,YES,7648f957-bca6-426a-be43-5bc8f9082ea8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HZ,TCGA-3B-A9HZ-01A,Primary Tumor,7648f957-bca6-426a-be43-5bc8f9082ea8,e3d7da576068af4a87a9ba2865d013c6,252897,released,6,10,5,21,Leiomyosarcoma,LMS,HRD-low
fc2da9a1-773c-4b3a-bfd6-7e4fb911e536.htseq.counts,TCGA-QQ-A5VC,CB6AC223-425A-430B-B44B-4A127757621D,Leiomyosarcoma (LMS),39,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,260,United States,80,0,573,YES,YES,YES,[Not Available],No,No,Consented,17,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,8023538a-53bf-43d4-bdad-8bc8ba71695e,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-QQ-A5VC,TCGA-QQ-A5VC-01A,Primary Tumor,8023538a-53bf-43d4-bdad-8bc8ba71695e,e3d0576a265f577f6e96b92d1d8dbc37,252723,released,28,30,17,75,Leiomyosarcoma,LMS,HRD-high
fc3748e5-79b4-4e5f-b0db-1d9cf4ed3cca.htseq.counts,TCGA-UE-A6QU,03A583F8-5976-4F26-A074-A9D058138447,Undifferentiated Pleomorphic Sarcoma (UPS),0,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cassette,YES,2985,Vietnam,95,0,0,YES,YES,NO,Pathology analysis at TSS determined a specific histological subtype different from original pathology report,No,No,Consented,0,[Not Available],Slide,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,05f747f7-ebd0-4f86-a0e6-692b5b1de337,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-UE-A6QU,TCGA-UE-A6QU-01A,Primary Tumor,05f747f7-ebd0-4f86-a0e6-692b5b1de337,c08b3ade3e990032e4d2028609bb4195,250521,released,26,28,14,68,Undiferentiated Pleomorphic Sarcoma (UPS),UPS,HRD-high
fca51e84-4783-4e3a-b4a0-85371ce84e43.htseq.counts,TCGA-WK-A8XT,B0B4CAD8-F539-4A2F-86F4-F183513C2816,Synovial Sarcoma,8,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryovial,YES,100,United States,95,0,1873,YES,YES,YES,[Not Available],"Yes, History of Synchronous/Bilateral Malignancy",No,Consented,-918,[Not Available],NO,Retroperitoneum,[Not Available],[Not Available],[Not Available],YES,NO,5dcbd52d-0111-490f-960d-e9ba676305a8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-WK-A8XT,TCGA-WK-A8XT-01A,Primary Tumor,5dcbd52d-0111-490f-960d-e9ba676305a8,60bac91a8de3ce40cef6aa255fc82924,254709,released,2,2,0,4,Synovial Sarcoma,SS,HRD-low
fd700b77-843b-49a6-800d-545b5f2bab90.htseq.counts,TCGA-SI-A71O,9947F0B3-1A35-4370-AD31-633B0740B0BF,Malignant Peripheral Nerve Sheath Tumors (MPNST),0,YES,Excisional Biopsy,[Not Applicable],Biospecimen Storage Bag,Other,YES,550,United States,95,40,165,YES,YES,YES,[Not Available],No,No,Consented,62,[Not Available],NO,Extremities,[Not Available],[Not Available],[Not Available],NO,YES,92ca0f7f-7682-40ef-8bd3-ee09d1cd0acd,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-SI-A71O,TCGA-SI-A71O-06A,Metastatic,92ca0f7f-7682-40ef-8bd3-ee09d1cd0acd,1c8e6465bc1bc57c27a9e35a164e253e,252561,released,24,21,24,69,Malignant Peripheral Nerve Sheath Tumors (MPNST),MPNST,HRD-high
feb05cdb-3124-4020-96cd-3369d7657d56.htseq.counts,TCGA-DX-A8BZ,08011518-9DE2-4BE0-B0EB-72F099BB7E9F,Leiomyosarcoma (LMS),46,YES,Surgical Resection,[Not Applicable],[Not Applicable],Cryomold,YES,200,United States,90,20,100,YES,YES,YES,[Not Available],No,No,Consented,17,[Not Available],NO,Superficial Trunk,[Not Available],[Not Available],[Not Available],NO,YES,8ea07c16-001a-4480-addc-01a3be8a75f8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-DX-A8BZ,TCGA-DX-A8BZ-01A,Primary Tumor,8ea07c16-001a-4480-addc-01a3be8a75f8,55cd6e324e34390b2052897d3a2ae4a4,240748,released,13,7,10,30,Leiomyosarcoma,LMS,HRD-low
ff0f98ba-a00f-4dc5-ac2d-9f0d1cd38366.htseq.counts,TCGA-3B-A9HT,C1379CE9-9782-4508-A702-254B4963DDEA,Leiomyosarcoma (LMS),19,YES,Surgical Resection,[Not Applicable],Biospecimen Storage Bag,Other,YES,105,United States,100,20,83,YES,YES,YES,[Not Available],No,No,Consented,11,[Not Available],NO,Head/Neck,[Not Available],[Not Available],[Not Available],NO,YES,eb65059f-0d36-4b54-ac0b-08bcddfabde8,Transcriptome Profiling,Gene Expression Quantification,TCGA-SARC,TCGA-3B-A9HT,TCGA-3B-A9HT-01A,Primary Tumor,eb65059f-0d36-4b54-ac0b-08bcddfabde8,643657a078b04b43ae280b98a819b02b,252164,released,14,7,2,23,Leiomyosarcoma,LMS,HRD-low